Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
A2M	"CPAMD5, FWP007, S863-7"	ENSG00000175899	Alpha-2-macroglobulin	P01023	12	9067664-9116229	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 231.0;lung: 227.4"	"Group enriched"	"Detected in some"	5	"AF22: 111.0;ASC diff: 33.0;Hep G2: 89.4;SK-MEL-30: 32.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 4.4"	"Group enriched"	"Detected in many"	7	"dendritic cells: 1.4;T-cells: 4.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA002265, CAB017621"	Supported				"Secreted to blood"	2900000000000	220000000000			"CAB017621: AB_1118894, HPA002265: AB_1078142"	"unprognostic (1.73e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.29e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.95e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.19e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.04e-3)"	"unprognostic (2.32e-2)"	"unprognostic (8.58e-2)"	"unprognostic (9.03e-3)"	77.4	20.5	12.5	14.7	16.8	0.3	39.6	6.1	16.1	41.8	27.3	25.3	10.5	15.0	54.6	28.2	39.5	30.6	49.7	68.0	12.4	10.2	50.0	231.0	227.4	14.9	16.9	8.0	40.8	13.0	20.9	20.4	48.0	20.5	77.3	35.9	47.5	20.5	26.3	26.0	10.2	23.1	57.7	20.9	42.3	25.8	26.2	13.0	4.0	29.5	17.0	8.6	68.9	59.0	0.2	1.4	0.0	0.4	0.0	4.4	0.3	0.0	0.0	111.0	0.0	33.0	2.4	0.3	13.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	89.4	0.0	0.1	0.1	5.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	32.1	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.1	0.0	0.1	0.0	0.0	2.1	0.0	0.4	0.0	4.4	0.2	2.6	0.2	0.5	1.2	0.3	0.0	0.1	0.7	0.0	0.0	0.0	1.4	0.0	0.3	12.5	16.8	6.1	16.1	12.4	10.2	16.9	8.0	20.5	13.0
ABCA8	KIAA0822	ENSG00000141338	"ATP binding cassette subfamily A member 8"	O94911	17	68867292-68955392	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"ASC diff: 16.2;ASC TERT1: 36.1;HSkMC: 27.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044914	Enhanced		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA044914: AB_10964859"	"unprognostic (2.58e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.04e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.22e-2)"	"unprognostic (6.68e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.29e-1)"	"unprognostic (6.14e-3)"	29.1	25.2	10.0	3.4	27.2	0.5	15.1	3.2	15.4	7.3	12.8	29.9	3.9	5.4	10.2	13.0	12.4	17.6	14.3	30.0	12.5	5.5	8.1	26.6	15.2	1.3	37.8	9.2	44.7	5.1	4.5	14.8	7.6	22.2	10.3	14.3	16.4	9.8	7.9	8.9	4.9	9.9	7.1	28.2	9.9	11.5	15.8	42.7	0.0	13.0	14.2	2.8	13.6	20.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.9	0.0	16.2	36.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	6.0	0.0	0.0	27.3	0.0	0.4	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	10.0	27.2	3.2	15.4	12.5	5.5	37.8	9.2	22.2	42.7
ABCA9	EST640918	ENSG00000154258	"ATP binding cassette subfamily A member 9"	Q8IUA7	17	68974488-69061064	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 42.5"	"Group enriched"	"Detected in some"	6	"ASC diff: 14.2;ASC TERT1: 30.4;HSkMC: 10.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052113, HPA054823"	Uncertain		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA052113: , HPA054823: "	"unprognostic (3.88e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.21e-1)"	"unprognostic (9.75e-2)"	"unprognostic (4.46e-1)"	"unprognostic (5.64e-3)"	"unprognostic (4.51e-4)"	"unprognostic (1.83e-2)"	"unprognostic (1.94e-3)"	"unprognostic (7.86e-2)"	"unprognostic (3.26e-3)"	"unprognostic (3.51e-1)"	"unprognostic (7.77e-6)"	"unprognostic (5.32e-4)"	"unprognostic (7.22e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.96e-3)"	42.5	4.2	1.2	5.5	2.8	1.7	14.1	2.7	2.6	13.4	17.4	2.6	6.8	1.7	15.5	11.8	25.5	8.8	7.2	15.0	2.1	1.9	2.5	7.6	5.6	2.1	7.8	2.0	25.2	2.3	1.7	2.8	1.1	4.4	13.9	3.8	4.1	5.7	4.7	12.4	5.4	3.7	11.9	3.8	1.6	4.8	10.9	2.1	1.0	7.6	9.9	2.5	20.4	18.7	1.8	0.9	2.9	0.8	1.2	1.3	0.0	0.2	0.4	0.5	0.6	14.2	30.4	0.5	0.3	0.3	0.0	0.2	0.3	0.4	0.4	0.1	0.5	0.4	0.2	0.5	0.2	0.2	0.4	0.5	1.2	0.4	1.5	0.6	0.9	10.8	0.4	2.2	0.2	3.0	0.5	1.0	0.2	0.2	0.2	1.4	0.3	0.3	1.4	0.1	0.2	0.1	1.3	0.5	0.4	0.4	0.3	0.2	0.3	0.5	1.3	0.9	0.4	1.6	0.3	1.0	0.3	0.3	0.3	0.3	1.4	1.7	0.8	1.4	1.3	0.6	1.3	1.1	0.8	0.5	0.9	1.8	1.3	1.3	2.9	1.2	0.5	0.7	0.4	0.0	1.2	2.8	2.7	2.6	2.1	1.9	7.8	2.0	4.4	2.1
ABCD2	"ALDL1, ALDR, ALDRP"	ENSG00000173208	"ATP binding cassette subfamily D member 2"	Q9UBJ2	12	39550033-39619751	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 24.1;brain: 30.1"	"Group enriched"	"Detected in some"	5	"ASC diff: 9.0;HDLM-2: 12.1;Karpas-707: 21.7;SH-SY5Y: 13.1;U-266/70: 7.4"	"Cancer enriched"	"Detected in single"	7	"glioma: 1.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Lineage enriched"	"Detected in many"	4	"T-cells: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.26e-3)"	"unprognostic (4.06e-4)"	"unprognostic (9.27e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.06e-1)"	"unprognostic (7.31e-5)"	"unprognostic (3.42e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.06e-3)"	"unprognostic (3.43e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.47e-4)"	"unprognostic (5.04e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.74e-2)"	24.1	3.6	6.8	3.5	6.8	0.9	5.5	30.1	13.4	10.6	1.7	1.3	0.0	1.4	5.4	1.0	1.3	5.2	1.4	7.4	5.1	4.1	1.4	0.7	1.4	4.8	4.8	8.4	0.7	0.7	0.7	5.1	0.5	11.4	1.2	1.7	2.9	4.6	1.6	0.7	0.7	1.7	5.1	2.1	3.0	1.6	0.9	2.6	0.9	1.0	0.6	3.2	2.8	1.9	0.8	0.8	0.1	0.0	1.4	6.5	1.8	0.0	0.0	0.1	0.0	9.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	21.7	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	7.4	0.9	0.1	0.0	0.2	0.0	0.0	0.0	0.0	2.4	0.0	1.9	0.8	4.3	5.7	0.2	0.4	5.0	6.5	0.1	1.4	0.0	0.8	5.1	1.8	6.8	6.8	30.1	13.4	5.1	4.1	4.8	8.4	11.4	2.6
AC025165.3		ENSG00000257921			12	57773028-57787046	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"pancreas: 14.2;salivary gland: 16.5"	"Group enriched"	"Detected in some"	27	"ASC diff: 3.6;fHDF/TERT166: 1.6;HMC-1: 1.9;Karpas-707: 1.7;RH-30: 4.6"	"Cancer enriched"	"Detected in single"	6	"glioma: 0.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (1.28e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.38e-4)"	"unprognostic (3.74e-2)"	"unprognostic (6.78e-4)"	"unprognostic (2.19e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.27e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.46e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.74e-2)"	3.0	1.2	1.4	0.8	1.3	0.8	3.4	1.4	1.5	2.4	1.3	0.0	2.8	0.8	3.3	2.3	1.7	0.8	2.5	0.8	0.9	1.0	3.7	1.7	2.1	3.3	1.2	0.1	3.6	14.2	0.8	0.8	0.9	0.4	2.3	2.0	1.6	16.5	5.3	0.8	0.8	0.8	2.0	2.5	0.8	1.0	1.0	0.0	0.0	2.4	1.1	1.7	2.3	0.7	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.3	1.4	1.5	0.9	1.0	1.2	0.1	0.4	0.0
ACSM5	FLJ20581	ENSG00000183549	"Acyl-CoA synthetase medium chain family member 5"	Q6NUN0	16	20409534-20441336	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"liver: 94.6"	"Group enriched"	"Detected in some"	5	"ASC diff: 5.6;ASC TERT1: 12.3;HSkMC: 14.6;U-87 MG: 9.0"	"Group enriched"	"Detected in some"	7	"liver cancer: 20.5;renal cancer: 9.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 2.8;intermediate monocyte: 1.9;myeloid DC: 3.2;non-classical monocyte: 1.3"	"Group enriched"	"Detected in many"	8	"dendritic cells: 3.2;monocytes: 2.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA041435	Uncertain		Uncertain	Vesicles				Vesicles		"HPA041435: AB_10961121"	"unprognostic (1.01e-1)"	"unprognostic (1.61e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.11e-3)"	"unprognostic (2.09e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.57e-1)"	11.1	1.1	1.9	0.7	2.1	0.4	3.2	1.3	1.6	1.0	1.0	2.9	0.0	0.5	0.3	2.8	0.5	0.6	1.0	0.9	3.0	1.9	8.9	94.6	0.9	1.6	2.9	2.1	0.4	1.4	0.4	0.1	0.7	2.0	0.4	0.6	0.5	0.5	0.5	4.4	0.6	0.6	0.5	2.9	1.7	0.9	1.0	3.0	0.1	1.7	0.6	0.4	0.5	0.7	0.3	3.2	0.3	2.8	0.0	0.3	0.5	0.0	0.0	0.1	0.1	5.6	12.3	0.0	0.1	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.2	0.0	14.6	0.0	0.8	0.1	0.0	0.1	0.6	1.7	0.0	0.0	0.3	0.2	0.0	0.0	0.1	2.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	9.0	0.1	0.0	0.3	2.8	0.1	0.1	1.9	0.1	0.1	0.3	0.2	3.2	0.3	0.2	0.3	0.1	0.0	1.3	0.1	0.0	0.5	1.9	2.1	1.3	1.6	3.0	1.9	2.9	2.1	2.0	3.0
ACVR1C	"ACVRLK7, ALK7"	ENSG00000123612	"Activin A receptor type 1C"	Q8NER5	2	157526767-157629005	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 36.2;breast: 15.3"	"Group enriched"	"Detected in some"	4	"ASC diff: 15.1;HDLM-2: 6.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.8"	"Lineage enriched"	"Detected in single"	4	"T-cells: 2.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basal ganglia: 29.2;cerebral cortex: 8.1;hippocampal formation: 21.6"	"HPA007982, HPA011933"	Approved				"Intracellular and membrane"					"HPA007982: AB_1078134, HPA011933: AB_1844754"	"unprognostic (1.03e-1)"	"unprognostic (4.55e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.92e-1)"	"unprognostic (7.64e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.12e-3)"	"unprognostic (3.62e-1)"	"unprognostic (9.31e-6)"	"unprognostic (7.28e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.30e-1)"	36.2	3.7	3.9	2.7	10.3	0.7	15.3	1.6	4.4	0.9	9.4	2.7	0.0	5.5	0.7	1.0	0.8	0.8	1.8	1.0	9.2	3.1	1.1	3.3	0.8	1.2	3.7	3.1	5.1	2.4	0.5	12.0	0.7	3.5	0.9	4.4	0.0	1.5	1.0	1.3	0.7	4.4	0.8	2.8	0.8	3.4	1.1	4.0	0.0	0.9	0.5	1.0	0.6	2.9	0.6	0.0	0.0	0.0	0.0	2.8	0.4	2.0	0.0	0.0	0.1	15.1	0.4	0.3	0.4	0.4	0.1	0.5	2.2	0.2	0.0	0.2	1.2	0.0	0.1	0.0	0.3	6.6	1.0	0.0	0.0	0.5	0.0	0.0	1.1	0.1	0.0	0.4	0.0	0.0	0.0	0.4	0.4	0.2	0.0	0.0	1.3	0.7	0.0	0.8	0.1	0.0	0.0	0.4	0.0	0.0	0.0	2.3	0.0	0.3	0.0	0.8	0.2	0.0	0.2	0.8	2.4	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.5	0.0	1.0	0.6	1.8	1.2	0.0	0.5	2.8	1.1	0.0	0.0	0.0	0.0	0.0	0.4	3.9	10.3	1.6	4.4	9.2	3.1	3.7	3.1	3.5	4.0
ADRA1A	"ADRA1C, ADRA1L1"	ENSG00000120907	"Adrenoceptor alpha 1A"	P35348	8	26748150-26867273	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"liver: 45.1"	"Group enriched"	"Detected in some"	5	"ASC diff: 1.3;HAP1: 1.8;NTERA-2: 2.4;U-2 OS: 1.5"	"Cancer enhanced"	"Detected in some"		"liver cancer: 0.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029678, HPA029679"	Approved	Supported								"HPA029678: AB_10602108, HPA029679: "	"unprognostic (1.27e-1)"		"unprognostic (1.68e-2)"		"unprognostic (1.99e-1)"	"unprognostic (3.57e-1)"	"unprognostic (5.04e-4)"	"unprognostic (1.97e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.58e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.06e-3)"	"unprognostic (7.41e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.30e-1)"	14.5	0.7	7.1	1.1	3.9	0.3	3.4	6.2	4.9	0.9	1.5	5.9	4.9	1.0	1.8	2.0	0.9	0.6	0.5	10.1	11.6	2.0	0.8	45.1	3.9	1.4	4.7	4.7	1.0	0.5	0.3	0.6	0.3	3.8	10.2	0.7	0.6	4.6	11.2	0.6	0.9	1.3	2.4	1.9	7.0	1.2	0.5	4.2	0.0	0.6	0.1	0.6	0.6	0.7	0.3	0.0	0.3	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.3	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.0	7.1	3.9	6.2	4.9	11.6	2.0	4.7	4.7	3.8	4.2
AKR1C1	"DD1, DDH, DDH1, HAKRC, MBAB"	ENSG00000187134	"Aldo-keto reductase family 1 member C1"	Q04828	10	4963253-4983283	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 145.9;tongue: 74.5"	"Group enriched"	"Detected in many"	10	"ASC diff: 186.6;Hep G2: 316.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 64.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.2"	"Low lineage specificity"	"Detected in many"											"CAB047303, HPA068265"	Enhanced		Enhanced	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"		"CAB047303: , HPA068265: "	"unprognostic (1.54e-2)"	"prognostic favourable (3.05e-4)"	"unprognostic (4.04e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.05e-2)"	"prognostic unfavourable (1.56e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.65e-1)"	"unprognostic (1.82e-2)"	"prognostic favourable (8.03e-9)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.72e-2)"	"unprognostic (6.30e-2)"	52.0	3.8	2.1	3.4	4.1	1.4	36.0	2.6	2.7	2.2	3.2	2.6	1.2	6.2	1.4	4.0	19.2	1.7	16.1	22.1	2.6	2.6	32.0	145.9	11.2	2.5	5.4	1.4	3.8	4.9	0.6	4.1	0.7	6.6	5.1	3.2	3.8	13.1	3.4	17.1	4.7	4.6	4.8	6.8	0.9	21.9	5.2	3.2	0.0	11.5	74.5	5.0	17.4	10.8	0.0	0.9	4.2	0.1	0.3	1.7	0.8	0.0	25.6	0.1	25.8	186.6	22.5	0.0	0.8	5.7	0.3	0.2	0.5	0.0	0.0	0.3	5.8	0.2	0.0	1.3	0.1	0.0	0.0	0.7	4.2	316.4	1.8	0.1	0.0	11.4	1.6	2.7	1.6	0.6	5.5	0.0	4.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	4.8	0.0	0.1	1.4	0.0	0.0	0.0	0.4	5.0	2.2	0.1	5.9	0.2	0.1	0.0	0.0	7.9	0.7	0.0	4.2	0.1	1.1	1.7	0.0	0.1	0.0	0.7	0.4	0.2	0.0	0.3	1.5	0.9	0.3	0.0	0.9	0.4	0.8	2.1	4.1	2.6	2.7	2.6	2.6	5.4	1.4	6.6	3.2
AKR1C2	"BABP, DD, DD2, DDH2, HAKRD, MCDR2, TDD"	ENSG00000151632	"Aldo-keto reductase family 1 member C2"	P52895	10	4987400-5018031	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 71.9;liver: 122.7;tongue: 111.8"	"Group enriched"	"Detected in some"	4	"A549: 134.6;ASC diff: 167.1;Hep G2: 251.2;RT4: 76.9"	"Group enriched"	"Detected in many"	6	"cervical cancer: 21.7;head and neck cancer: 31.5;liver cancer: 50.2;lung cancer: 69.0;urothelial cancer: 35.7"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.4"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.4"									"CAB047304, HPA068265"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"				"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"CAB047304: , HPA068265: "	"unprognostic (6.77e-2)"	"unprognostic (8.88e-3)"	"unprognostic (3.02e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.86e-2)"	"unprognostic (8.65e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.25e-3)"	"unprognostic (8.58e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.46e-2)"	"unprognostic (8.30e-2)"	60.4	4.0	1.8	2.0	3.3	0.0	71.9	2.5	2.1	1.3	2.9	1.0	1.2	5.5	1.0	3.0	17.4	1.5	19.4	9.3	1.7	2.3	4.8	122.7	5.9	1.1	4.7	0.9	1.9	2.4	0.0	1.8	0.1	4.2	8.1	2.4	2.0	12.0	2.4	19.8	4.2	2.4	4.4	3.9	0.6	26.2	2.3	2.6	0.1	4.2	111.8	5.5	25.3	11.9	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	134.6	0.1	14.2	167.1	5.7	0.0	0.0	0.5	0.0	0.1	0.5	0.0	0.0	0.7	0.9	3.8	0.0	0.7	0.0	0.0	0.0	0.0	38.0	251.2	0.3	0.0	0.0	14.9	8.4	0.7	0.7	0.0	5.1	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.2	76.9	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.5	0.3	0.1	4.9	0.0	0.0	0.0	0.0	1.7	2.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.8	3.3	2.5	2.1	1.7	2.3	4.7	0.9	4.2	2.6
ANGPT4		ENSG00000101280	"Angiopoietin 4"	Q9Y264	20	869899-916317	"Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 18.7;breast: 12.3;cervix, uterine: 16.8"	"Group enriched"	"Detected in some"	80	"ASC diff: 21.1;BEWO: 30.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 2.4"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB013260, CAB013305"	Uncertain				"Secreted to blood"					"CAB013260: , CAB013305: "	"unprognostic (1.77e-1)"	"unprognostic (3.25e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.04e-3)"	"unprognostic (6.37e-2)"	"unprognostic (3.41e-1)"	"unprognostic (5.82e-4)"	"unprognostic (1.25e-1)"	"unprognostic (7.10e-2)"	"unprognostic (3.66e-4)"	"unprognostic (9.01e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.95e-4)"	"unprognostic (9.14e-2)"	18.7	0.7	0.1	0.1	0.3	0.1	12.3	0.0	0.5	16.8	1.4	0.6	2.1	0.2	7.1	4.9	1.2	3.5	2.5	1.1	0.1	0.3	0.4	0.1	2.6	0.1	0.3	0.0	4.8	0.2	0.1	0.0	0.4	0.3	1.8	0.1	2.4	1.3	2.2	0.2	1.4	0.3	2.6	0.1	0.1	0.4	3.7	0.0	0.0	2.1	1.6	0.4	1.3	2.2	0.3	0.6	2.4	0.9	0.2	0.3	0.5	0.1	0.0	0.0	0.0	21.1	0.0	30.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.9	0.4	0.2	0.5	0.0	0.1	0.2	0.3	0.6	0.3	0.1	0.2	0.8	0.2	0.6	0.2	0.0	0.5	0.1	0.3	0.0	0.5	0.1	0.3	0.3	0.0	0.3	0.0
ANGPTL1	"ANG3, ANGPT3, AngY, ARP1"	ENSG00000116194	"Angiopoietin like 1"	O95841	1	178849705-178871052	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	18	"ASC diff: 47.6;ASC TERT1: 19.2;HHSteC: 20.6;HSkMC: 46.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.3;naive B-cell: 2.9"	"Lineage enhanced"	"Detected in single"		"B-cells: 2.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA009976	Approved				"Secreted to blood"		100000			"HPA009976: AB_1844822"	"unprognostic (2.59e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.80e-3)"	"unprognostic (2.63e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.71e-2)"	"prognostic favourable (8.73e-4)"	"unprognostic (3.81e-2)"	"unprognostic (5.78e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.31e-2)"	"prognostic favourable (5.11e-4)"	"unprognostic (1.49e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.61e-3)"	17.7	16.3	1.2	8.5	1.1	0.0	14.4	0.7	1.4	26.3	36.2	0.9	9.6	2.6	34.6	46.5	33.6	29.7	16.6	12.9	1.0	0.6	15.9	7.1	12.4	15.8	0.6	2.5	35.7	6.4	0.0	2.2	42.0	1.6	16.7	8.7	0.9	14.2	4.2	20.0	4.5	28.2	22.7	1.8	7.0	13.1	24.7	0.4	0.9	19.3	57.5	2.8	25.5	13.7	2.9	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	47.6	19.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	20.6	0.0	0.0	46.9	0.0	0.6	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	2.9	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.2	1.1	0.7	1.4	1.0	0.6	0.6	2.5	1.6	0.4
ANGPTL5		ENSG00000187151	"Angiopoietin like 5"	Q86XS5	11	101890674-101916522	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 9.4;ovary: 24.9"	"Group enriched"	"Detected in some"	6	"ASC diff: 7.7;ASC TERT1: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.0"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"			HPA038516	Uncertain				"Secreted in other tissues"					"HPA038516: AB_10672749"	"unprognostic (8.28e-3)"	"unprognostic (3.08e-2)"		"unprognostic (1.21e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.23e-2)"		"unprognostic (2.18e-1)"		"unprognostic (4.88e-2)"	"unprognostic (6.74e-4)"	"unprognostic (1.96e-1)"	"unprognostic (1.53e-8)"	"unprognostic (3.40e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.17e-3)"	9.4	0.3	0.2	0.0	0.3	0.0	6.4	0.2	0.7	1.3	0.3	0.0	0.6	0.1	0.1	5.0	1.0	0.4	0.3	3.7	0.2	0.2	0.1	0.2	1.0	0.1	2.0	0.5	24.9	0.0	0.0	0.3	0.1	0.8	1.4	0.2	0.0	0.5	0.3	1.9	3.5	0.5	1.3	1.7	0.0	0.2	6.2	0.3	0.2	2.4	2.9	0.0	1.8	1.1	0.7	1.0	0.0	0.0	0.9	0.3	0.0	0.0	0.1	0.0	0.0	7.7	2.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.7	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.9	0.0	1.0	0.0	0.0	0.2	0.3	0.2	0.7	0.2	0.2	2.0	0.5	0.8	0.3
APOD		ENSG00000189058	"Apolipoprotein D"	P05090	3	195568702-195584205	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"breast: 840.7"	"Group enriched"	"Detected in some"	7	"ASC diff: 233.9;ASC TERT1: 126.0"	"Cancer enhanced"	"Detected in all"		"melanoma: 925.2"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"memory B-cell: 6.7"	"Lineage enriched"	"Detected in single"	10	"B-cells: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040520	Enhanced		Approved	"Plasma membrane"	"Secreted to blood"	27730000	220000000000	"Plasma membrane"		"HPA040520: "	"prognostic favourable (5.51e-4)"	"unprognostic (7.62e-3)"	"unprognostic (7.85e-3)"	"unprognostic (3.34e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.19e-1)"	"unprognostic (6.90e-3)"	"prognostic unfavourable (6.02e-4)"	"unprognostic (1.38e-1)"	"prognostic unfavourable (4.12e-4)"	"unprognostic (1.71e-3)"	134.4	15.2	39.7	5.7	39.9	3.4	840.7	14.7	66.1	75.0	16.4	79.7	10.9	12.9	36.6	30.0	46.1	42.9	36.4	124.7	45.5	29.2	8.5	3.5	11.8	6.5	96.9	28.2	19.4	28.3	9.0	14.3	59.6	50.9	39.7	13.1	99.1	152.5	35.1	110.4	66.0	7.2	30.4	81.6	3.6	28.7	32.0	56.5	0.0	87.7	42.2	6.6	62.1	95.7	6.7	0.1	0.4	0.6	0.0	0.1	0.1	0.0	0.1	0.0	0.0	233.9	126.0	0.3	2.0	0.5	0.0	0.0	12.9	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	6.4	1.4	0.0	1.1	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.3	2.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	25.3	0.4	0.1	0.0	0.1	0.1	0.0	6.7	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.6	0.1	0.0	0.1	39.7	39.9	14.7	39.5	45.5	29.2	96.9	28.2	50.9	56.5
AVPR1A	AVPR1	ENSG00000166148	"Arginine vasopressin receptor 1A"	P37288	12	63142759-63150942	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 34.9;liver: 71.2"	"Group enriched"	"Detected in some"	12	"ASC diff: 6.8;Karpas-707: 15.1;U-266/84: 10.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basal ganglia: 7.1;hypothalamus: 4.4"	"Low region specificity"	"Detected in all"														"unprognostic (1.49e-1)"	"unprognostic (2.82e-1)"	"unprognostic (9.90e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.43e-3)"	"unprognostic (3.79e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.58e-6)"	"unprognostic (1.45e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.38e-3)"	"unprognostic (4.65e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.66e-4)"	26.4	34.9	0.3	2.8	0.3	0.0	6.3	0.2	0.4	9.7	4.2	0.5	1.1	0.2	16.5	2.1	2.5	3.7	3.4	2.5	0.3	0.3	4.2	71.2	0.7	1.5	0.3	0.0	3.8	1.5	1.1	1.0	1.2	0.6	3.2	0.5	0.5	1.1	2.4	4.4	1.3	0.8	7.5	0.3	0.5	1.5	1.8	0.0	0.6	6.1	3.0	0.4	6.2	2.6	0.0	0.0	0.9	0.0	0.0	0.0	1.2	0.2	0.2	0.7	0.0	6.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.2	0.3	0.3	0.2	0.4	0.3	0.3	0.3	0.0	0.6	0.0
BTLA	"BTLA1, CD272"	ENSG00000186265	"B and T lymphocyte associated"	Q7Z6A9	3	112463968-112499561	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 37.2;lymphoid tissue: 30.9"	"Group enriched"	"Detected in some"	4	"ASC diff: 2.4;Daudi: 1.9;U-698: 6.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 22.6;naive B-cell: 37.2"	"Lineage enriched"	"Detected in many"	4	"B-cells: 37.2"	"Not detected"	"Not detected"							"HPA047211, HPA062029"	Enhanced									"HPA047211: , HPA062029: "	"unprognostic (1.13e-3)"	"unprognostic (2.13e-3)"	"unprognostic (5.79e-4)"	"unprognostic (1.01e-4)"	"unprognostic (7.08e-2)"	"unprognostic (7.74e-6)"	"unprognostic (6.20e-3)"	"unprognostic (7.59e-3)"	"unprognostic (5.98e-2)"	"unprognostic (1.53e-5)"	"unprognostic (2.33e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.57e-5)"	"unprognostic (2.57e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.42e-2)"	0.6	0.3	0.3	20.3	0.4	1.2	1.1	0.4	0.3	0.5	1.2	0.1	0.0	0.9	0.4	0.1	2.3	0.5	1.0	0.4	0.3	0.3	1.0	0.5	1.2	30.9	0.3	0.0	0.4	0.3	0.0	0.4	0.3	0.1	0.5	0.9	0.2	5.7	0.4	0.3	0.5	6.0	0.2	0.4	18.6	1.7	0.6	0.0	14.6	0.9	1.1	19.4	2.8	0.5	37.2	8.6	0.1	0.0	0.1	5.1	2.4	0.0	0.0	0.0	0.3	2.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.9	0.1	0.1	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.1	0.1	0.0	0.0	0.0	0.0	0.0	4.1	0.0	3.1	22.6	5.1	2.4	1.5	37.2	4.8	4.7	0.1	0.1	0.0	8.6	1.1	2.4	0.3	0.4	0.4	0.3	0.3	0.3	0.3	0.0	0.1	0.0
C1QTNF7	CTRP7	ENSG00000163145	"C1q and TNF related 7"	Q9BXJ2	4	15339818-15446166	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 39.6"	"Group enriched"	"Detected in some"	5	"ASC diff: 9.0;ASC TERT1: 6.2;HSkMC: 3.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	14	"neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 1.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB007055, HPA051797, HPA055392"	Uncertain		Approved	Vesicles	"Secreted to blood"	238000000		Vesicles		"CAB007055: , HPA051797: , HPA055392: "	"unprognostic (6.61e-2)"	"unprognostic (4.50e-2)"	"unprognostic (6.16e-2)"	"unprognostic (6.50e-4)"	"unprognostic (1.24e-1)"	"unprognostic (4.98e-3)"	"unprognostic (2.31e-2)"	"unprognostic (7.69e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.97e-4)"	"unprognostic (3.01e-3)"	"unprognostic (8.31e-2)"	"unprognostic (7.56e-3)"	"unprognostic (7.28e-3)"	16.0	0.9	0.6	24.7	0.8	0.0	7.4	0.3	0.7	39.6	12.0	0.5	3.3	0.6	24.6	10.1	17.3	6.2	20.3	5.4	0.6	0.6	4.0	1.0	7.9	0.5	0.8	0.5	15.9	1.3	0.0	1.4	5.4	0.8	22.0	3.2	5.4	2.7	2.4	2.2	3.5	4.1	22.1	0.7	10.2	10.4	4.4	0.1	0.3	4.2	13.0	2.0	16.3	15.8	0.1	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	6.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	3.3	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.3	0.7	0.6	0.6	0.8	0.5	0.8	0.1
C6		ENSG00000039537	"Complement C6"	P13671	5	41142234-41261438	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"	"Complement pathway, Cytolysis, Immunity, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"liver: 176.1"	"Group enriched"	"Detected in some"	13	"ASC diff: 5.1;ASC TERT1: 7.1;HSkMC: 18.8"	"Group enriched"	"Detected in many"	7	"liver cancer: 49.0;pancreatic cancer: 12.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA043823, CAB069427"	Enhanced				"Secreted to blood"		7600000000			"CAB069427: AB_1614336, HPA043823: AB_10960262"	"unprognostic (9.79e-2)"	"unprognostic (1.96e-2)"	"unprognostic (5.94e-3)"	"unprognostic (3.02e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.12e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.04e-3)"	"prognostic favourable (4.31e-4)"	"unprognostic (2.69e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.51e-2)"	2.3	0.1	0.2	0.1	0.2	0.0	1.0	0.1	0.2	0.3	0.5	0.5	0.1	0.1	0.2	2.7	0.3	8.8	2.4	24.1	0.2	0.0	5.2	176.1	0.9	0.8	0.1	0.1	3.2	10.1	0.0	0.4	0.4	0.6	0.2	0.0	0.2	0.1	0.1	0.2	0.0	0.8	0.1	0.2	0.1	0.4	1.7	0.1	0.1	0.4	0.7	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	7.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.2	0.0	18.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.2	0.0	0.1	0.1	0.6	0.1
C7		ENSG00000112936	"Complement C7"	P10643	5	40909252-40982939	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 199.9"	"Group enriched"	"Detected in some"	9	"ASC diff: 37.6;HHSteC: 49.7;HSkMC: 68.4;SH-SY5Y: 46.4"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 73.8"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA001465	Approved				"Secreted to blood"		67000000000			"HPA001465: AB_1078554"	"unprognostic (5.01e-2)"	"unprognostic (3.74e-2)"	"unprognostic (7.40e-2)"	"unprognostic (4.68e-3)"	"unprognostic (5.35e-2)"	"unprognostic (1.43e-3)"	"prognostic favourable (5.89e-4)"	"unprognostic (6.67e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.24e-2)"	"unprognostic (6.10e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.06e-3)"	54.4	99.5	0.8	7.4	1.6	0.0	10.5	1.1	1.0	30.2	34.7	3.1	14.8	2.5	36.8	48.6	55.3	47.7	48.2	79.7	0.9	0.3	81.3	41.0	29.1	69.0	3.9	1.5	199.9	32.4	3.0	5.2	55.4	3.7	52.5	4.8	1.4	5.1	17.5	1.9	1.8	17.0	43.3	3.2	33.6	17.9	44.6	0.7	3.1	32.4	1.1	7.2	39.9	29.6	0.7	0.4	1.6	0.3	1.5	0.4	0.0	0.0	0.0	0.0	0.0	37.6	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.7	0.0	0.0	68.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	46.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.4	0.2	0.3	0.1	0.2	0.2	0.2	0.0	0.7	0.3	0.4	1.1	1.5	0.3	0.4	0.0	0.0	0.8	1.6	1.1	1.0	0.9	0.3	3.9	1.5	3.7	0.7
CD36	"FAT, GP3B, GP4, GPIV, SCARB3"	ENSG00000135218	"CD36 molecule"	P16671	7	80369575-80679277	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion, Transport"	Receptor	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 464.3;breast: 156.1"	"Group enriched"	"Detected in some"	5	"ASC diff: 80.8;HEL: 38.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"classical monocyte: 104.4;intermediate monocyte: 30.4;myeloid DC: 56.9"	"Group enriched"	"Detected in many"	45	"dendritic cells: 56.9;monocytes: 104.4"	"Low region specificity"	"Detected in many"							"HPA002018, CAB025866, HPA071026"	Enhanced		Enhanced	"Golgi apparatus"			92000000	"Golgi apparatus"		"CAB025866: , HPA002018: AB_1078464, HPA071026: "	"unprognostic (7.16e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.63e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.84e-3)"	"prognostic unfavourable (4.47e-4)"	"unprognostic (7.05e-3)"	"unprognostic (4.87e-2)"	"unprognostic (2.73e-3)"	464.3	3.6	1.2	8.9	1.3	10.9	156.1	0.5	0.5	1.8	31.8	0.6	3.3	9.8	1.8	7.5	7.5	3.3	7.2	76.8	1.8	1.9	2.2	13.3	11.5	4.8	0.6	0.3	2.5	3.9	3.1	0.8	37.9	2.9	9.2	3.5	0.8	4.6	2.3	23.6	5.4	23.4	4.7	0.8	42.8	5.0	6.0	0.5	2.7	13.6	15.3	1.4	9.4	19.2	0.3	56.9	1.8	104.4	0.7	0.2	60.2	0.0	0.0	0.2	0.1	80.8	0.8	0.1	0.2	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	1.0	0.1	0.0	0.1	0.1	38.4	0.1	6.1	0.0	0.0	0.0	7.8	3.1	0.0	0.0	0.2	1.3	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.3	0.2	0.1	0.0	2.7	4.4	0.0	0.1	0.5	0.1	0.0	0.0	0.1	0.1	0.0	13.2	10.2	0.9	104.4	0.3	0.2	30.4	0.2	0.3	0.0	0.0	56.9	0.0	0.1	0.0	1.8	0.7	7.5	14.3	0.1	60.2	1.2	1.3	0.5	0.5	1.8	1.9	0.6	0.3	2.9	0.5
CFD	"ADN, DF, PFD"	ENSG00000197766	"Complement factor D"	P00746	19	859643-863630	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement alternate pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"ASC diff: 39.8;THP-1: 56.5"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 125.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 125.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"	731723333	8000000000				"unprognostic (3.00e-2)"	"unprognostic (6.09e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.22e-3)"	"unprognostic (6.92e-2)"	"unprognostic (5.28e-2)"	"unprognostic (8.11e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.46e-2)"	"unprognostic (8.10e-2)"	"prognostic favourable (1.77e-4)"	"unprognostic (9.53e-2)"	"prognostic unfavourable (7.09e-4)"	"unprognostic (1.23e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.92e-2)"	"unprognostic (9.75e-2)"	161.3	4.6	0.0	16.4	0.0	5.6	96.7	0.0	1.7	44.2	35.2	0.2	42.2	10.9	8.9	89.8	54.1	15.6	59.0	102.0	0.0	0.0	1.9	2.3	34.0	6.2	0.0	0.0	13.7	6.0	1.7	0.1	20.2	0.1	102.0	4.3	3.4	22.7	15.1	40.5	35.8	16.5	97.3	0.1	3.7	19.7	33.6	0.0	0.8	52.6	55.6	9.0	83.7	130.3	0.6	5.6	125.0	25.8	0.1	1.0	10.4	0.7	1.9	0.0	0.3	39.8	6.2	2.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.5	0.2	0.0	0.0	1.1	2.8	0.0	1.7	0.6	0.6	0.3	1.0	6.3	0.0	0.0	0.0	0.0	2.3	0.1	0.0	0.9	0.0	8.9	0.1	2.8	0.2	0.0	0.9	0.0	0.1	0.3	0.3	0.8	0.2	0.0	1.1	56.5	0.0	0.0	0.9	0.4	0.1	1.7	0.7	0.0	0.0	3.3	0.0	125.0	18.2	58.8	0.7	20.1	1.0	0.6	0.5	0.9	5.6	0.2	0.7	0.8	43.2	0.1	25.8	0.5	0.3	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
CHIA	"AMCase, CHIT2, TSA1902"	ENSG00000134216	"Chitinase, acidic"	Q9BZP6	1	111290862-111320566	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Carbohydrate metabolism, Chitin degradation, Immunity, Inflammatory response, Polysaccharide degradation"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"stomach 1: 66.6"	"Group enriched"	"Detected in some"	4	"ASC diff: 5.9;HAP1: 3.1"	"Cancer enhanced"	"Detected in some"		"lung cancer: 1.8;stomach cancer: 2.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.6"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"			HPA059193	Approved				"Intracellular and membrane"					"HPA059193: "				"unprognostic (8.00e-2)"	"unprognostic (7.08e-2)"			"unprognostic (2.02e-2)"					"unprognostic (4.99e-2)"	"unprognostic (7.93e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.06e-2)"		0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.7	0.5	0.8	0.3	0.1	0.1	0.1	0.0	0.5	1.0	13.2	0.2	0.1	0.1	0.1	0.1	0.6	0.5	0.1	0.1	0.1	0.0	0.1	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.1	66.6	0.5	0.1	0.1	0.5	0.1	0.1	0.1	0.1	1.6	0.7	0.0	0.1	0.6	0.6	0.3	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.7	0.2	0.2	0.0	1.6	0.6	0.0	0.0	0.6	0.0	0.7	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CHRDL1	"CHL, MGC1, NRLN1"	ENSG00000101938	"Chordin like 1"	Q9BU40	X	110673856-110795819	"Disease related genes, Predicted secreted proteins"	"Differentiation, Neurogenesis, Osteogenesis"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	11	"ASC diff: 93.7;ASC TERT1: 128.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	24	"plasmacytoid DC: 2.5"	"Lineage enriched"	"Detected in single"	24	"dendritic cells: 2.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000226, HPA000250"	Approved				"Secreted in other tissues"		620000			"HPA000226: AB_1078522, HPA000250: AB_1078521"	"unprognostic (5.13e-2)"	"unprognostic (6.31e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.48e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.72e-2)"	"unprognostic (7.26e-3)"	"unprognostic (1.42e-2)"	"unprognostic (4.89e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.56e-1)"	"prognostic unfavourable (2.36e-4)"	"unprognostic (4.75e-3)"	"unprognostic (7.91e-2)"	"unprognostic (5.01e-2)"	"prognostic unfavourable (2.23e-4)"	53.1	2.2	7.2	11.5	12.3	0.2	40.8	3.7	8.4	22.0	25.7	1.4	40.9	3.1	57.3	29.5	18.7	18.1	14.2	22.0	5.4	1.7	4.5	0.7	27.6	7.5	1.7	6.8	7.5	3.6	51.4	2.8	15.2	2.2	46.1	11.1	15.2	8.5	73.9	3.2	6.9	7.7	31.0	3.4	6.5	8.6	5.8	2.4	0.8	14.9	23.7	3.4	16.3	11.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	93.7	128.9	0.0	1.2	0.5	3.1	2.7	0.0	0.0	0.0	0.0	0.1	0.0	3.7	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.6	9.8	1.2	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	7.2	12.3	3.7	8.4	5.4	1.7	1.7	6.8	2.2	2.4
CNR1	"CANN6, CB-R, CB1, CB1A, CB1K5, CNR"	ENSG00000118432	"Cannabinoid receptor 1"	P21554	6	88139864-88166359	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.5"	"Group enriched"	"Detected in some"	7	"ASC diff: 39.4;HSkMC: 26.0"	"Cancer enriched"	"Detected in many"	13	"glioma: 12.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory B-cell: 2.9;naive B-cell: 2.1"	"Lineage enriched"	"Detected in single"	6	"B-cells: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042256, HPA069945"	Enhanced		Supported	"Plasma membrane,Actin filaments"				"Plasma membrane"	"Actin filaments"	"HPA042256: , HPA069945: "	"unprognostic (1.28e-1)"	"unprognostic (7.04e-2)"	"unprognostic (4.61e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.07e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.59e-3)"	"unprognostic (2.68e-3)"	"unprognostic (5.88e-2)"	"unprognostic (7.00e-2)"	19.4	6.4	18.0	5.2	15.8	1.5	14.9	13.8	30.5	3.9	5.5	0.8	0.8	2.3	3.1	4.7	3.7	5.5	3.6	1.4	17.6	7.7	0.9	0.7	6.4	6.5	2.3	14.7	4.1	1.8	1.3	18.3	5.2	4.2	1.5	5.1	0.0	4.3	4.0	1.7	2.4	4.2	5.8	3.2	2.3	2.3	2.7	2.8	0.0	2.6	0.0	9.9	2.7	3.1	2.9	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	39.4	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.1	0.8	1.3	0.0	2.6	0.0	0.0	26.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.2	0.0	3.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.6	2.2	0.0	0.0	0.0	0.0	0.0	0.7	3.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	2.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	18.0	15.8	13.8	21.4	17.6	7.7	2.3	14.7	4.2	2.8
CRLF1	"CISS, CISS1, CLF, CLF-1"	ENSG00000006016	"Cytokine receptor like factor 1"	O75462	19	18572220-18607741	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		Receptor	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	11	"ASC diff: 147.5;Hep G2: 61.2"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 36.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	7	"hippocampal formation: 23.3"	"Not detected"	"Not detected"			"HPA041493, HPA041793"	Approved				"Secreted in other tissues"					"HPA041493: AB_10795637, HPA041793: AB_10804117"	"unprognostic (1.97e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.34e-3)"	"unprognostic (9.31e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.34e-3)"	"unprognostic (4.95e-2)"	"unprognostic (7.92e-2)"	"prognostic unfavourable (3.96e-4)"	"unprognostic (1.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.86e-2)"	"unprognostic (5.27e-3)"	15.8	10.4	6.6	2.7	21.2	1.2	19.8	0.8	19.8	14.3	3.6	14.8	6.8	2.2	4.3	18.8	10.4	4.6	7.8	35.0	5.0	3.3	3.6	1.6	5.1	6.0	0.5	8.5	2.4	6.9	1.7	3.2	26.6	4.3	2.0	1.9	0.3	5.8	12.8	30.5	15.1	1.5	3.8	0.8	1.5	2.4	5.6	3.4	0.0	31.9	10.0	1.6	4.3	4.9	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	1.4	147.5	2.1	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	9.3	4.4	0.0	1.4	0.0	0.0	0.0	0.1	0.0	2.6	61.2	1.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	1.8	0.0	0.1	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.6	21.2	0.8	13.6	5.0	3.3	0.5	8.5	4.3	3.4
CRYAB	"CRYA2, HSPB5"	ENSG00000109846	"Crystallin alpha B"	P02511	11	111908565-111923722	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Chaperone, Eye lens protein"	"Cancer-related genes, Cardiomyopathy, Cataract, Disease mutation, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 743.1;skeletal muscle: 581.1"	"Group enriched"	"Detected in some"	5	"ASC diff: 230.1;fHDF/TERT166: 75.0"	"Group enriched"	"Detected in all"	6	"glioma: 426.4;renal cancer: 575.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002053, CAB040560, HPA057100"	Enhanced		Enhanced	"Plasma membrane,Cytosol"			12000	"Plasma membrane, Cytosol"		"CAB002053: AB_442024, CAB040560: , HPA057100: "	"unprognostic (1.06e-2)"	"unprognostic (2.26e-1)"	"prognostic unfavourable (4.90e-5)"	"unprognostic (2.46e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.41e-3)"	"unprognostic (9.29e-3)"	"unprognostic (7.35e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.68e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.68e-2)"	"unprognostic (7.92e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (1.70e-5)"	107.4	11.5	47.8	16.7	82.3	2.1	69.5	24.8	153.7	22.4	23.6	132.9	7.2	5.5	14.8	25.9	41.9	13.5	14.0	743.1	65.9	44.0	151.8	3.8	8.4	3.9	139.2	29.7	8.8	6.6	3.3	8.6	16.1	80.7	30.3	12.9	23.3	30.6	75.1	581.1	18.1	6.2	45.2	168.0	5.5	11.6	3.9	101.8	0.0	40.7	94.1	9.2	16.2	53.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.3	230.1	10.1	1.6	6.4	0.2	0.1	0.2	0.1	0.0	0.0	3.8	75.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	1.2	0.6	1.9	0.0	0.0	8.1	1.0	0.0	0.5	0.0	0.5	0.2	18.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.4	0.8	3.4	0.5	0.0	0.1	29.8	10.7	0.8	0.3	0.1	0.0	0.0	0.6	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.8	82.3	24.8	48.5	65.9	44.0	139.2	29.7	80.7	101.8
CTSK	"CTSO, CTSO2, PKND, PYCD"	ENSG00000143387	"Cathepsin K"	P43235	1	150796208-150808323	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Thiol protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 104.1"	"Group enriched"	"Detected in some"	8	"ASC diff: 200.2;ASC TERT1: 73.3;BJ hTERT+: 161.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 6.7"	"Lineage enriched"	"Detected in many"	6	"monocytes: 6.7"	"Low region specificity"	"Detected in all"							HPA050346			Supported	Vesicles	"Intracellular and membrane"			Vesicles		"HPA050346: "	"unprognostic (1.48e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.61e-3)"	"unprognostic (5.08e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.60e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.54e-2)"	"prognostic unfavourable (7.12e-5)"	"unprognostic (6.07e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.93e-3)"	"unprognostic (6.41e-2)"	104.1	2.4	1.2	6.5	1.6	1.3	79.3	2.4	2.3	70.6	23.6	2.2	10.1	2.7	72.5	25.9	26.5	12.5	53.4	14.7	1.1	1.1	3.4	1.8	8.7	10.4	1.1	1.7	25.4	2.9	0.3	3.0	30.6	2.6	24.2	11.5	56.0	10.9	6.8	19.9	44.0	11.0	26.9	2.0	5.6	8.6	24.1	0.9	1.1	7.1	13.2	10.7	38.0	48.2	0.1	1.0	1.0	6.7	0.5	1.2	1.8	0.1	0.1	0.3	0.3	200.2	73.3	0.2	5.7	161.8	0.4	0.8	0.0	0.1	0.1	0.2	11.1	0.2	0.0	0.1	0.2	0.1	0.1	0.3	0.1	0.0	1.0	0.1	0.4	14.6	0.5	4.5	0.1	0.6	0.0	0.5	0.4	0.3	0.0	0.7	1.1	0.1	0.0	0.1	0.0	0.4	0.1	0.1	0.6	0.3	0.0	3.0	0.2	0.2	0.4	0.2	0.1	0.2	0.2	0.6	0.5	1.1	17.0	0.0	0.9	0.0	6.7	1.0	0.7	3.4	0.2	0.0	0.6	0.2	0.4	0.1	0.3	0.5	0.6	0.5	2.0	1.0	1.2	1.8	1.2	1.6	2.4	2.3	1.1	1.1	1.1	1.7	2.6	0.9
DPT		ENSG00000143196	Dermatopontin	Q07507	1	168695459-168729264	"Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 128.1"	"Group enriched"	"Detected in some"	13	"ASC diff: 54.0;fHDF/TERT166: 21.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065548			Approved	Vesicles	"Secreted to extracellular matrix"		25000	Vesicles		"HPA065548: "	"unprognostic (1.49e-1)"	"unprognostic (7.62e-2)"	"unprognostic (5.66e-2)"	"unprognostic (4.39e-2)"	"unprognostic (4.64e-2)"	"unprognostic (3.78e-3)"	"unprognostic (4.09e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.16e-2)"	"prognostic unfavourable (4.74e-5)"	"unprognostic (2.12e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.98e-3)"	128.1	6.1	0.8	22.6	0.8	0.0	99.3	0.8	2.4	51.0	81.7	0.9	19.8	2.4	20.4	38.8	33.1	23.0	52.3	48.8	0.8	0.3	2.4	6.0	9.6	7.7	0.8	0.8	12.8	13.4	0.0	0.9	7.8	0.9	24.0	9.4	1.8	14.4	10.2	13.0	8.6	23.1	76.1	0.8	1.0	23.6	8.7	0.8	2.3	16.3	55.7	22.8	48.7	39.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.0	0.2	0.0	0.0	2.4	2.6	2.7	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.8	2.4	0.8	0.3	0.8	0.8	0.9	0.8
ECM2		ENSG00000106823	"Extracellular matrix protein 2"	O94769	9	92493554-92536655	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"ASC diff: 11.1;ASC TERT1: 20.3;HSkMC: 21.4;hTCEpi: 24.4;hTERT-HME1: 6.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035347	Approved				"Secreted to extracellular matrix"		5500000			"HPA035347: AB_10669856"	"unprognostic (2.48e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.20e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.30e-1)"	"prognostic favourable (4.50e-5)"	"unprognostic (6.14e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (4.09e-6)"	"unprognostic (1.12e-3)"	"unprognostic (2.39e-2)"	"unprognostic (3.80e-2)"	"unprognostic (6.63e-3)"	43.3	5.0	5.4	7.2	4.3	0.0	18.6	9.5	1.9	20.9	6.5	5.4	11.6	2.9	14.7	27.5	8.4	11.6	11.2	13.8	9.3	3.6	10.1	28.2	8.8	2.3	11.0	4.2	34.6	1.9	4.9	4.7	1.4	17.8	16.4	2.4	5.8	3.4	8.1	6.0	5.8	5.4	10.1	15.8	0.5	2.8	15.4	7.4	1.1	8.3	15.5	2.4	13.7	8.8	0.3	0.6	0.0	0.5	0.1	0.5	0.0	0.4	0.0	0.2	0.0	11.1	20.3	0.7	0.4	0.6	0.0	0.3	0.3	0.0	0.0	0.0	1.0	0.3	0.5	0.4	0.0	2.4	0.0	0.0	0.0	0.0	1.9	0.1	0.0	21.4	24.4	0.5	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.4	0.4	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.5	0.0	0.1	0.4	0.0	0.3	0.0	0.0	0.5	0.2	0.5	0.0	0.0	0.1	0.1	0.6	0.0	0.0	5.4	4.3	9.5	1.9	9.3	3.6	11.0	4.2	17.8	7.4
FABP4	"A-FABP, aP2"	ENSG00000170323	"Fatty acid binding protein 4"	P15090	8	81478419-81483263	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"adipose tissue: 492.7;breast: 545.8"	"Group enriched"	"Detected in some"	325	"ASC diff: 275.5;RT4: 136.3"	"Group enriched"	"Detected in all"	7	"breast cancer: 42.1;cervical cancer: 141.7;head and neck cancer: 133.8;urothelial cancer: 65.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002188, CAB024961"	Enhanced						30000000			"CAB024961: , HPA002188: AB_1078822"	"unprognostic (4.81e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.64e-3)"	"unprognostic (2.63e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.70e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.13e-3)"	"unprognostic (4.48e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.39e-1)"	492.7	3.5	0.3	16.1	0.3	0.1	545.8	0.2	0.2	0.9	42.2	0.0	1.8	0.2	0.6	2.9	4.8	1.0	7.6	15.6	0.3	0.3	1.2	0.4	9.3	4.7	0.3	0.0	0.7	1.3	2.2	0.3	15.9	0.3	7.7	2.9	0.1	7.6	1.7	13.0	5.5	4.5	3.3	0.3	0.7	2.2	6.1	0.0	0.7	7.4	7.3	0.1	15.4	60.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	275.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	136.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.2	0.3	0.3	0.3	0.0	0.3	0.0
FAM107A	"DRR1, TU3A"	ENSG00000168309	"Family with sequence similarity 107 member A"	O95990	3	58564117-58627610	"Predicted intracellular proteins"	"Cell cycle, Growth regulation, Stress response"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 149.7"	"Group enriched"	"Detected in some"	7	"ASC diff: 11.4;HUVEC TERT2: 34.8"	"Cancer enriched"	"Detected in many"	6	"glioma: 110.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055888	Enhanced		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA055888: "	"unprognostic (1.20e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavourable (3.56e-4)"	"unprognostic (3.11e-1)"	"unprognostic (7.80e-3)"	"prognostic favourable (3.38e-4)"	"unprognostic (1.92e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.73e-2)"	"unprognostic (7.82e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.95e-3)"	22.4	4.6	119.4	4.7	86.5	1.3	8.4	32.4	149.7	17.0	7.6	68.6	1.7	3.6	9.4	25.1	13.9	39.6	8.4	15.8	91.5	52.0	12.4	3.5	18.1	2.4	66.6	44.3	4.3	11.1	4.1	12.0	13.8	33.5	16.3	8.4	10.7	17.5	19.4	7.5	3.5	5.8	19.8	77.5	12.0	5.8	2.5	87.2	1.2	9.9	1.4	4.8	6.5	10.2	0.3	0.3	1.3	0.9	0.7	0.6	0.1	0.0	0.0	0.5	0.0	11.4	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	34.8	0.0	0.4	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	1.9	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.2	1.3	0.4	0.5	0.3	0.4	0.6	0.2	0.3	0.2	0.2	0.3	0.2	0.3	0.6	0.7	0.9	0.3	0.3	0.1	119.4	86.5	32.4	80.7	91.5	52.0	66.6	44.3	33.5	87.2
FFAR3	"FFA3R, GPR41"	ENSG00000185897	"Free fatty acid receptor 3"	O14843	19	35358460-35360485	"G-protein coupled receptors, Predicted membrane proteins"	"Immunity, Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 6.5;blood: 5.6;lymphoid tissue: 6.1"	"Group enriched"	"Detected in some"	5	"ASC diff: 1.1;HHSteC: 3.8;HSkMC: 3.3;U-937: 1.4"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	5	"eosinophil: 4.7;neutrophil: 5.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 5.6"									HPA044681	Uncertain									"HPA044681: "	"unprognostic (1.15e-1)"		"unprognostic (5.16e-3)"		"unprognostic (1.45e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.21e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.92e-4)"	"unprognostic (3.80e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.04e-3)"	"unprognostic (2.18e-2)"	"unprognostic (3.41e-1)"	"unprognostic (3.22e-2)"	6.5	0.0	0.1	6.1	0.3	1.7	3.8	0.0	0.2	0.0	2.1			0.7	0.0	0.0	0.0	0.5	1.1	0.2	0.4	0.2	0.0	0.5	0.6	0.4	0.5		0.3	1.0	0.4	0.5	0.9		0.2	0.1		0.0	0.0	0.0	0.0	0.9	3.7	1.5	2.4	1.3	0.0			0.9		0.0	0.7	0.0	0.0	0.1	5.6	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.4	0.0	0.1	4.7	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.6	0.0	0.3	0.0	0.0	0.2										
FMO2		ENSG00000094963	"Flavin containing monooxygenase 2"	Q99518	1	171185208-171211230	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 40.0;esophagus: 35.3;lung: 53.0"	"Group enriched"	"Detected in some"	57	"ASC diff: 24.0;ASC TERT1: 10.9;HSkMC: 28.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			HPA028261	Approved									"HPA028261: AB_10601012"	"unprognostic (1.85e-2)"	"unprognostic (3.14e-2)"	"unprognostic (7.44e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.00e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.28e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.26e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.83e-2)"	40.0	11.8	1.2	1.7	4.4	0.0	22.5	1.5	0.6	7.6	5.0	0.6	2.9	0.3	1.9	3.5	35.3	6.7	2.0	17.4	1.8	1.2	9.4	1.8	53.0	5.7	3.9	1.2	6.1	2.1	1.8	7.0	0.0	2.4	6.0	0.7	8.3	14.0	1.3	7.6	1.7	1.5	2.5	1.9	0.4	2.4	3.3	1.3	0.4	5.8	6.8	5.5	5.0	10.2	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	28.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.2	4.4	1.5	0.6	1.8	1.2	3.9	1.2	2.4	1.3
FMO3		ENSG00000007933	"Flavin containing monooxygenase 3"	P31513	1	171090877-171117819	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"liver: 170.2"	"Group enriched"	"Detected in some"	4	"ASC diff: 24.8;ASC TERT1: 18.8"	"Cancer enriched"	"Detected in many"	13	"liver cancer: 94.9"	"Region enriched"	"Detected in single"	5	"pons and medulla: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA013750	Enhanced									"HPA013750: AB_1848968"	"unprognostic (1.87e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.81e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.31e-3)"	"prognostic favourable (3.46e-4)"	"prognostic favourable (5.60e-5)"	"unprognostic (2.95e-1)"	"unprognostic (9.34e-2)"	"unprognostic (3.02e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavourable (1.13e-4)"	"unprognostic (1.84e-1)"	"unprognostic (2.59e-1)"	"unprognostic (3.45e-1)"	"unprognostic (7.27e-2)"	9.5	2.0	0.0	0.8	0.2	0.0	1.3	0.1	0.1	0.2	0.8	0.1	0.1	0.3	0.6	1.2	1.7	2.3	0.3	0.8	0.0	0.1	6.4	170.2	3.7	1.5	0.2	0.0	0.9	0.7	0.3	2.7	0.0	1.4	0.2	0.1	3.6	0.9	0.1	1.9	0.8	0.4	0.2	0.1	0.1	0.6	0.5	0.1	0.0	0.8	1.2	2.6	0.2	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.8	18.8	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.2	0.0	1.4	0.1
G0S2		ENSG00000123689	"G0/G1 switch 2"	P27469	1	209675420-209676388	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 203.9;liver: 154.7"	"Group enriched"	"Detected in some"	6	"ASC diff: 75.4;HBEC3-KT: 113.8;PC-3: 28.6;RPMI-8226: 36.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	62	"neutrophil: 89.5"	"Lineage enriched"	"Detected in single"	197	"granulocytes: 89.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.67e-3)"	"unprognostic (1.99e-3)"	"prognostic unfavourable (7.72e-4)"	"unprognostic (1.54e-2)"	"prognostic unfavourable (1.20e-4)"	"unprognostic (3.82e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.04e-3)"	"unprognostic (3.03e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.32e-2)"	"unprognostic (8.12e-2)"	"prognostic unfavourable (3.14e-4)"	"unprognostic (7.57e-3)"	"unprognostic (1.53e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.64e-1)"	130.1	23.3	1.1	18.5	1.1	203.9	85.2	2.0	0.9	2.0	11.3	1.4	29.9	1.6	6.1	9.3	2.0	4.0	13.5	43.7	1.1	0.8	22.2	154.7	51.6	6.4	1.8	0.0	18.4	5.3	0.5	1.2	2.6	1.3	8.7	1.1	3.1	49.2	73.5	97.9	3.0	3.5	3.8	1.5	6.3	7.1	5.3	1.1	0.0	3.1	14.3	6.1	12.6	13.1	0.0	0.0	89.5	0.1	0.0	0.4	0.0	0.0	0.6	0.0	0.0	75.4	2.6	0.0	0.1	0.2	0.3	0.3	2.9	2.3	0.0	0.6	0.5	0.0	0.0	113.8	0.7	0.1	0.2	0.0	0.2	0.0	6.1	0.0	0.0	7.8	0.2	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.2	28.6	0.0	0.0	36.3	0.2	0.0	0.1	0.2	2.5	0.0	0.6	0.0	8.7	11.4	0.0	0.7	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.1	1.4	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	89.5	0.0	0.0	0.0	0.0	0.0	1.1	1.1	2.0	0.9	1.1	0.8	1.8	0.0	1.3	1.1
GALNT15	"GALNT7, GALNTL2, pp-GalNAc-T15"	ENSG00000131386	"Polypeptide N-acetylgalactosaminyltransferase 15"	Q8N3T1	3	16174649-16231992	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 66.7;brain: 52.3"	"Group enriched"	"Detected in some"	5	"ASC diff: 43.8;ASC TERT1: 43.2;HSkMC: 32.9"	"Cancer enriched"	"Detected in many"	5	"glioma: 21.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"cerebellum: 10.7;pons and medulla: 6.7"	"Low region specificity"	"Detected in all"			HPA017076	Uncertain		Approved	"Golgi apparatus,Cytosol"	"Intracellular and membrane"		25000	"Golgi apparatus"	Cytosol	"HPA017076: AB_1849458"	"unprognostic (3.87e-1)"	"unprognostic (4.84e-4)"	"unprognostic (6.39e-2)"	"unprognostic (8.77e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.40e-4)"	"unprognostic (4.24e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.28e-6)"	"unprognostic (5.13e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.88e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.78e-3)"	66.7	5.3	7.6	2.6	17.4	1.1	22.8	2.3	31.5	3.9	8.6	28.1	1.1	2.8	3.5	3.3	11.4	5.3	5.2	7.3	14.8	6.6	8.3	2.8	3.1	3.4	38.9	8.4	8.4	3.2	1.6	1.0	35.5	24.8	4.9	3.8	1.3	8.0	4.1	17.3	11.6	5.3	10.5	52.3	12.8	4.6	8.1	19.9	0.0	6.3	1.6	1.5	16.6	23.5	0.6	0.9	0.9	0.3	0.3	0.4	0.3	0.0	0.0	0.0	0.0	43.8	43.2	0.0	0.9	0.7	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	32.9	0.0	0.4	0.5	0.6	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.1	7.7	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.5	0.2	0.3	0.2	0.2	0.1	0.4	0.2	0.3	0.0	0.6	0.4	0.2	0.9	0.3	0.3	0.9	0.3	0.3	7.6	17.4	2.3	13.6	14.8	6.6	38.9	8.4	24.8	19.9
GGT5	"GGT-REL, GGTLA1"	ENSG00000099998	"Gamma-glutamyltransferase 5"	P36269	22	24219654-24245142	"Enzymes, Predicted intracellular proteins"	"Glutathione biosynthesis, Leukotriene biosynthesis"	"Acyltransferase, Hydrolase, Protease, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"ASC diff: 38.7;ASC TERT1: 29.4;HHSteC: 55.2;HSkMC: 63.6;TIME: 24.7"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in some"	5	"basophil: 4.0;eosinophil: 7.5;neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 7.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008121, CAB032489"	Uncertain		Approved	"Nucleoli fibrillar center"	"Intracellular and membrane"		18000000	"Nucleoli fibrillar center"		"CAB032489: AB_2111010, HPA008121: AB_1078965"	"unprognostic (8.14e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.66e-2)"	"unprognostic (9.94e-2)"	"unprognostic (8.13e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.37e-2)"	"unprognostic (7.94e-2)"	"prognostic unfavourable (6.36e-5)"	"prognostic unfavourable (4.06e-4)"	"prognostic unfavourable (6.97e-4)"	"unprognostic (1.79e-1)"	"unprognostic (8.33e-2)"	20.2	14.8	2.0	5.2	3.5	0.0	13.2	0.5	4.2	10.7	4.0			5.7	7.9	3.6	2.1	10.2	12.1	14.0	2.4	3.4	13.1	13.7	5.1	12.4	4.7		3.9	5.0	2.2	6.0	3.2		6.5	3.4		5.4	6.8	2.5	5.3	7.2	10.1	2.7	4.8	5.6	1.2			17.2		5.2	6.3	9.3	0.1	0.4	7.5	0.9	0.8	0.1	0.4	0.0	0.3	0.0	0.0	38.7	29.4	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.3	0.1	5.0	55.2	0.6	1.3	63.6	0.0	0.7	0.7	10.3	0.1	0.1	9.9	0.1	0.0	4.8	0.6	0.0	0.0	0.9	0.1	1.1	0.0	0.0	1.3	0.0	1.6	0.0	0.2	0.3	24.7	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.9	1.1	0.0	4.0	0.9	7.5	0.1	0.4	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	1.9	0.8	0.0	0.1	0.0	0.4										
ISM1	"bA149I18.1, C20orf82"	ENSG00000101230	"Isthmin 1"	B1AKI9	20	13221771-13300651	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 33.8"	"Group enriched"	"Detected in some"	5	"ASC diff: 35.4;Hep G2: 13.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 4.0;naive CD4 T-cell: 3.3"	"Lineage enriched"	"Detected in single"	40	"T-cells: 4.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"						"unprognostic (7.13e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.43e-3)"	"unprognostic (5.27e-3)"	"unprognostic (1.84e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavourable (9.32e-6)"	"unprognostic (2.58e-2)"	"unprognostic (2.10e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.81e-2)"	7.8	2.4	0.8	0.5	1.1	0.0	17.0	0.7	1.5	2.4	2.1	0.8	2.0	0.3	1.8	2.3	4.5	2.3	4.4	2.2	1.0	1.7	2.4	4.5	3.2	1.0	0.7	0.9	1.1	5.7	0.1	1.0	12.7	1.3	1.9	0.2	0.8	8.9	0.7	2.3	9.2	1.1	1.7	0.6	4.8	1.9	1.2	0.8	1.4	33.8	5.5	1.1	3.8	6.1	0.0	0.0	0.0	0.0	0.0	4.0	1.5	0.0	0.3	0.1	0.5	35.4	5.0	0.2	0.3	2.9	0.0	0.0	1.9	0.3	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	2.8	0.0	0.0	13.5	0.0	0.0	0.0	0.1	0.3	0.0	0.3	0.0	0.3	0.0	0.2	1.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	1.0	0.1	0.6	0.0	0.0	0.0	2.0	0.1	0.2	0.0	3.3	0.6	0.0	1.5	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.4	0.0	0.0	3.3	0.5	0.0	0.0	0.0	0.0	0.0	1.5	0.8	1.1	0.7	1.5	1.0	1.7	0.7	0.9	1.3	0.8
JAK2	JTK10	ENSG00000096968	"Janus kinase 2"	O60674	9	4984390-5128183	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"	"Chromatin regulator, Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"ASC diff: 18.9;HDLM-2: 26.7;HEL: 54.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 40.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 40.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013089, HPA040820, HPA043870"	Approved		Supported	"Nucleoplasm,Plasma membrane,Focal adhesion sites"				Nucleoplasm	"Plasma membrane, Focal adhesion sites"	"CAB013089: AB_2533647, HPA040820: , HPA043870: "	"unprognostic (2.24e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.50e-2)"	"unprognostic (7.67e-2)"	"unprognostic (5.50e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.85e-1)"	"unprognostic (4.53e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.37e-3)"	19.8	8.8	11.5	19.0	10.5	19.0	17.7	14.7	14.4	17.8	10.6	7.0	10.3	7.2	14.8	13.6	12.4	13.4	14.6	27.6	10.3	6.7	7.7	5.6	16.1	19.4	7.0	10.5	15.9	6.7	10.1	7.5	12.0	10.0	12.0	7.4	9.4	7.2	7.4	14.4	19.0	12.3	10.4	11.7	21.5	14.1	10.1	9.0	13.6	8.6	6.5	13.5	13.9	15.6	2.1	9.6	40.8	7.5	3.4	2.1	2.5	2.5	1.4	1.4	2.5	18.9	4.9	0.4	3.4	2.9	2.6	1.7	0.1	0.8	0.1	0.8	2.0	0.8	1.5	2.1	1.9	26.7	0.5	54.8	2.9	0.7	3.9	3.7	2.8	4.0	0.9	1.1	1.8	2.4	3.9	6.4	4.7	0.9	0.9	5.2	1.3	1.7	1.9	2.7	0.7	2.0	1.3	1.6	0.9	1.0	1.5	1.0	0.7	6.5	5.0	4.0	1.3	4.1	2.4	1.2	2.2	0.5	5.2	1.8	2.0	40.8	7.5	13.4	2.1	7.3	1.7	2.1	1.6	1.2	9.6	1.9	0.9	1.1	7.1	3.4	5.8	3.6	1.6	2.5	11.5	10.5	14.7	14.4	10.3	6.7	7.0	10.5	10.0	9.0
KLB		ENSG00000134962	"Klotho beta"	Q86Z14	4	39406853-39451536	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adipose tissue: 17.3;liver: 49.2;pancreas: 21.4"	"Group enriched"	"Detected in some"	23	"ASC diff: 6.4;Hep G2: 22.9"	"Cancer enriched"	"Detected in some"	16	"liver cancer: 11.6"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA021136	Uncertain						290000			"HPA021136: AB_1852616"	"unprognostic (1.03e-2)"	"unprognostic (1.61e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.30e-2)"	"unprognostic (7.02e-3)"	"unprognostic (2.46e-1)"	"unprognostic (9.92e-2)"	"unprognostic (6.99e-3)"	"unprognostic (4.51e-3)"	"unprognostic (3.02e-3)"	"unprognostic (8.90e-3)"	"unprognostic (1.73e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.09e-2)"	17.3	0.0	0.2	1.9	1.0	0.2	3.9	0.4	0.2	0.0	1.6	0.0	0.0	0.2	0.1	0.5	0.3	0.1	1.3	0.5	1.0	0.2	0.1	49.2	1.4	0.5	0.1	0.0	0.2	21.4	0.2	0.2	0.0	0.4	0.0	0.4	0.0	0.3	0.0	0.4	0.5	0.6	0.3	0.0	0.0	1.5	2.5	0.2	0.0	0.1	0.4	0.0	0.3	0.2	0.5	2.5	2.3	0.7	0.4	0.4	0.2	0.0	0.2	0.0	0.0	6.4	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	22.9	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.7	0.2	0.3	0.4	0.2	0.4	0.2	0.2	0.1	0.5	0.2	0.4	2.3	0.4	0.5	2.5	0.1	0.2	0.2	1.0	0.4	0.2	1.0	0.2	0.1	0.0	0.4	0.2
KRTAP20-2	KAP20.2	ENSG00000184032	"Keratin associated protein 20-2"	Q3LI61	21	30635236-30635619	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	12	"skin 1: 5.1"	"Group enriched"	"Detected in some"	22	"ASC diff: 3.2;U-2 OS: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LBP	BPIFD2	ENSG00000129988	"Lipopolysaccharide binding protein"	P18428	20	38346356-38377023	"Plasma proteins, Predicted secreted proteins, Transporters"	"Immunity, Innate immunity, Lipid transport, Transport"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	33	"liver: 429.7"	"Group enriched"	"Detected in some"	10	"ASC diff: 12.1;HSkMC: 14.3"	"Cancer enriched"	"Detected in many"	20	"liver cancer: 356.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001508, CAB025905"	Approved				"Secreted to blood"	25011600000	910000000			"CAB025905: , HPA001508: AB_1079241"	"unprognostic (4.20e-2)"	"prognostic unfavourable (5.56e-4)"	"unprognostic (4.54e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.53e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.48e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.93e-2)"	"unprognostic (2.62e-1)"	"prognostic unfavourable (3.62e-12)"	"prognostic unfavourable (5.76e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.67e-1)"	12.8	0.0	0.1	4.7	0.1	0.0	0.7	0.1	0.1	0.6	0.4	0.1	0.1	0.0	0.4	0.2	0.1	0.0	0.1	0.4	0.1	0.0	3.1	429.7	0.1	0.5	0.1	0.1	0.2	0.2	0.0	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.1	4.0	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	1.4	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.1	0.1	0.0	12.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.1	14.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.1	0.2	0.2	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
LGALS12	GRIP1	ENSG00000133317	"Galectin 12"	Q96DT0	11	63506084-63516774	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 45.1;blood: 90.2;breast: 28.6"	"Group enriched"	"Detected in some"	14	"ASC diff: 11.6;HL-60: 19.9;NB-4: 39.2;U-937: 42.1"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"basal ganglia: 1.1"	"Cell type enriched"	"Detected in some"	19	"eosinophil: 90.2"	"Lineage enriched"	"Detected in many"	19	"granulocytes: 90.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"														"unprognostic (3.89e-2)"	"unprognostic (4.40e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.26e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.13e-3)"	"unprognostic (4.69e-2)"	"unprognostic (3.08e-1)"	"prognostic unfavourable (4.60e-7)"	"unprognostic (2.72e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.22e-2)"	"unprognostic (8.60e-2)"	45.1	0.5	0.1	5.8	1.1	10.1	28.6	0.0	0.1	0.1	10.6	0.0	0.0	0.3	0.2	1.1	0.1	0.7	7.7	2.2	0.1	0.1	0.4	0.2	1.4	5.3	0.1	0.0	0.5	0.5	0.0	0.1	0.1	0.2	0.7	0.4	0.1	5.9	1.6	1.6	0.6	1.4	0.6	0.2	0.8	0.4	0.1	0.0	0.1	0.5	2.4	0.2	0.9	0.2	0.0	1.2	90.2	4.7	0.0	0.0	2.8	0.0	0.0	0.0	0.0	11.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	19.9	1.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	42.1	0.0	1.8	4.7	90.2	0.0	0.5	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	2.8	0.1	1.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.0
LMO3	"DAT1, RBTNL2, Rhom-3"	ENSG00000048540	"LIM domain only 3"	Q8TAP4	12	16548373-16610594	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 87.5"	"Group enriched"	"Detected in some"	8	"ASC diff: 69.0;LHCN-M2: 31.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 32.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"														"unprognostic (1.67e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.54e-2)"	"prognostic unfavourable (1.10e-7)"	"unprognostic (3.62e-2)"	"unprognostic (5.44e-2)"	"unprognostic (6.56e-3)"	"unprognostic (4.91e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.39e-5)"	"unprognostic (4.41e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.13e-3)"	"unprognostic (4.83e-2)"	15.9	8.3	38.1	3.1	43.9	1.2	8.2	5.2	87.5	13.1	22.6	5.8	6.4	2.0	8.7	3.4	3.1	2.1	6.3	3.6	20.8	9.4	4.0	1.3	30.0	1.3	14.5	27.6	9.6	29.6	2.1	7.9	2.1	12.9	11.2	9.9	0.9	4.1	25.7	1.2	1.3	4.3	16.9	4.2	1.4	2.6	1.7	8.6	0.3	30.4	0.0	1.2	15.9	6.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	31.1	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.9	0.4	5.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.1	43.9	5.2	42.5	20.8	9.4	14.5	27.6	12.9	8.6
LMOD1	"1D, 64kD, D1"	ENSG00000163431	"Leiomodin 1"	P29536	1	201896452-201946588	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 199.7;urinary bladder: 165.5"	"Group enriched"	"Detected in some"	10	"ASC diff: 11.1;BJ: 14.3;BJ hTERT+: 23.3;fHDF/TERT166: 11.5;HSkMC: 10.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 43.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028325, HPA028435, HPA030097"	Enhanced		Approved	Cytosol				Cytosol		"HPA028325: AB_10600300, HPA028435: AB_10602180, HPA030097: AB_10601223"	"unprognostic (3.84e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.64e-1)"	"unprognostic (6.35e-2)"	"prognostic favourable (2.52e-5)"	"unprognostic (1.27e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (1.05e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.15e-2)"	27.4	12.7	1.9	26.7	6.2	0.0	20.5	2.2	1.9	65.6	83.5	1.8	42.7	6.0	84.9	29.0	94.6	33.2	80.7	8.3	1.6	1.6	5.3	1.0	11.0	5.5	2.3	3.2	38.1	1.6	7.4	1.3	10.2	4.1	77.1	12.0	28.9	6.8	63.8	29.5	7.4	20.9	199.7	1.8	6.3	47.0	23.3	0.7	0.0	7.9	12.3	2.7	165.5	39.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	11.1	1.4	0.9	14.3	23.3	0.9	1.1	0.0	0.1	0.0	0.5	11.5	0.2	0.3	0.0	0.3	0.0	1.0	0.0	0.0	0.0	1.0	0.0	0.0	10.2	0.0	0.6	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.2	0.0	0.3	0.3	0.5	0.0	0.0	0.1	0.5	0.2	0.0	0.5	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.9	6.2	2.2	1.9	1.6	1.6	2.3	3.2	4.1	0.7
LRRC32	"D11S833E, GARP"	ENSG00000137507	"Leucine rich repeat containing 32"	Q14392	11	76657524-76670747	"Predicted intracellular proteins, Predicted membrane proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"ASC diff: 41.1;ASC TERT1: 25.3;HSkMC: 15.7;HUVEC TERT2: 17.8;U-2197: 37.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"neutrophil: 1.0;T-reg: 3.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 1.0;T-cells: 3.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA055775, HPA058434"			Enhanced	Nucleoplasm	"Intracellular and membrane"		19000	Nucleoplasm		"HPA055775: , HPA058434: "	"unprognostic (3.18e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.60e-2)"	"unprognostic (4.19e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.84e-2)"	"unprognostic (1.39e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.86e-2)"	"prognostic unfavourable (3.93e-5)"	"unprognostic (7.99e-3)"	"unprognostic (1.15e-2)"	"unprognostic (5.22e-3)"	"prognostic unfavourable (2.64e-4)"	50.5	16.5	5.4	8.0	11.3	1.9	35.1	4.6	9.1	19.8	12.4	4.4	3.5	7.0	15.2	10.4	11.1	10.8	22.6	18.0	7.6	3.5	19.5	8.5	51.8	4.7	10.2	4.3	19.9	8.7	7.9	7.0	40.5	10.1	12.6	5.1	16.6	5.2	9.4	29.0	9.9	7.7	13.0	5.7	21.2	8.1	8.6	8.7	0.6	16.6	9.7	2.1	19.8	25.1	0.2	0.0	1.0	0.0	0.0	3.1	9.6	0.0	0.0	0.4	0.0	41.1	25.3	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.2	0.0	0.8	0.0	0.0	15.7	0.0	1.4	0.0	17.8	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.7	2.6	0.3	37.7	0.0	0.0	0.0	0.6	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	3.1	9.6	5.4	11.3	4.6	9.1	7.6	3.5	10.2	4.3	10.1	8.7
MEDAG	"AWMS3, C13orf33, FLJ14834, MEDA-4"	ENSG00000102802	"Mesenteric estrogen dependent adipogenesis"	Q5VYS4	13	30906191-30925572	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 63.0"	"Group enriched"	"Detected in some"	4	"ASC diff: 76.2;ASC TERT1: 21.4;U-2197: 41.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"pons and medulla: 2.6"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"														"unprognostic (2.28e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.44e-2)"	"unprognostic (3.42e-2)"	"unprognostic (6.06e-3)"	"unprognostic (8.80e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavourable (3.29e-5)"	"unprognostic (8.69e-3)"	"unprognostic (2.48e-1)"	"unprognostic (5.41e-3)"	"unprognostic (7.52e-2)"	63.0	1.9	0.1	7.4	0.3	0.2	43.8	0.1	0.4	9.0	10.0	0.3	7.5	1.2	10.2	24.8	13.3	14.5	7.2	18.6	0.4	0.4	2.0	0.4	5.3	7.3	0.4	0.5	17.9	6.8	0.5	2.2	6.4	2.6	3.6	3.2	4.6	6.0	1.7	27.1	8.0	3.5	10.8	2.4	0.4	5.2	9.5	0.1	0.0	15.3	12.7	3.6	21.5	10.5	0.0	0.0	1.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	76.2	21.4	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	9.0	0.0	10.9	0.0	10.0	0.0	0.0	0.9	0.0	0.0	0.0	0.9	0.0	0.0	9.3	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.3	0.4	0.4	0.4	0.5	2.6	0.1
MRO	"B29, C18orf3, FLJ30140"	ENSG00000134042	Maestro	Q9BYG7	18	50795120-50825402	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 17.5;kidney: 24.3;testis: 30.9"	"Group enriched"	"Detected in some"	4	"ASC diff: 4.5;ASC TERT1: 13.7"	"Cancer enriched"	"Detected in some"	7	"glioma: 6.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022011	Approved									"HPA022011: AB_2670880"	"unprognostic (9.21e-5)"	"unprognostic (5.22e-2)"	"unprognostic (7.87e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.47e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.71e-1)"	"unprognostic (5.15e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.99e-3)"	"unprognostic (6.06e-4)"	2.7	3.2	12.2	0.9	13.9	0.6	1.0	4.5	17.5	0.7	0.7	13.9	1.0	8.3	0.5	4.1	0.9	0.7	1.7	4.4	15.4	5.9	24.3	7.7	0.7	0.7	9.1	10.3	3.8	2.2	3.8	1.3	1.2	11.1	0.7	0.6	1.6	0.7	2.7	2.4	0.5	5.3	0.7	10.7	2.5	1.8	30.9	12.4	0.0	6.6	0.0	0.5	0.8	0.6	0.8	0.9	2.1	1.2	0.5	0.4	0.0	0.0	0.0	0.1	0.3	4.5	13.7	1.1	0.0	0.0	0.0	0.0	0.2	0.2	0.4	2.1	0.1	0.0	0.3	0.0	0.0	0.4	0.6	0.1	0.4	0.2	0.4	0.1	0.0	1.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.3	0.2	0.0	0.2	1.0	0.5	0.2	0.3	0.9	0.3	0.4	0.3	0.3	0.1	0.8	0.4	0.4	2.1	0.5	1.2	0.9	0.2	0.0	12.2	13.9	4.5	11.2	15.4	5.9	9.1	10.3	11.1	12.4
OMD	"osteoadherin, SLRR2C"	ENSG00000127083	Osteomodulin	Q99983	9	92414245-92424461	"Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	14	"ASC diff: 12.3;ASC TERT1: 11.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069948			Approved	"Nucleoli fibrillar center,Endoplasmic reticulum"	"Secreted in other tissues"		14000000	"Endoplasmic reticulum"	"Nucleoli fibrillar center"	"HPA069948: "	"unprognostic (1.18e-1)"	"unprognostic (2.33e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.26e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.87e-2)"	"unprognostic (4.31e-3)"	"unprognostic (6.42e-2)"	"unprognostic (4.53e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.02e-3)"	"unprognostic (5.81e-3)"	"unprognostic (6.35e-2)"	"unprognostic (2.84e-3)"	"unprognostic (2.08e-3)"	14.0	7.9	2.2	1.2	4.3	0.0	14.6	3.7	3.4	20.3	8.3	1.0	8.0	0.8	8.2	19.3	14.0	8.7	8.9	20.2	2.8	1.7	2.9	0.8	12.2	0.8	7.0	5.4	15.3	1.8	1.5	4.2	11.5	6.0	13.6	2.2	14.2	2.3	4.2	2.8	3.5	3.7	13.9	19.3	0.7	5.0	12.8	1.3	0.2	9.2	14.5	3.2	22.1	7.6	0.3	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	12.3	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.3	0.0	0.2	0.0	0.3	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	2.2	4.3	3.7	3.4	2.8	1.7	7.0	5.4	6.0	1.3
OR2L13	OR2L14	ENSG00000196071	"Olfactory receptor family 2 subfamily L member 13"	Q8N349	1	248095184-248101103	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 3.2;brain: 7.3"	"Group enriched"	"Detected in some"	8	"ASC diff: 1.3;WM-115: 3.2"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"basophil: 3.2"	"Group enriched"	"Detected in many"	13	"B-cells: 1.0;granulocytes: 3.2;T-cells: 1.5"																				"unprognostic (1.39e-2)"				"unprognostic (1.53e-1)"				"unprognostic (9.89e-2)"	"unprognostic (3.66e-1)"		"unprognostic (7.01e-2)"			"unprognostic (2.44e-2)"	"unprognostic (1.14e-1)"		0.0	2.0	2.1	0.0	2.4	0.2	0.6	0.7	7.3	0.1	0.1			0.0	0.0	1.2	0.0	1.0	0.0	0.0	2.5	3.2	0.0	0.0	0.0	0.2	3.5		0.2	0.0	0.0	0.2	0.1		1.8	0.1		0.0	0.6	0.0	0.0	0.0	0.1	4.5	1.1	0.0	1.2			0.9		0.1	0.1	0.0	1.0	0.1	3.2	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.2	3.2	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.6	0.1	1.5	0.0	0.0	0.0	0.1	0.0	0.3										
PCDHGA5	"CDH-GAMMA-A5, ME3, PCDH-GAMMA-A5"	ENSG00000253485	"Protocadherin gamma subfamily A, 5"	Q9Y5G8	5	141364232-141512979	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 19.1"	"Group enriched"	"Detected in some"	7	"ASC diff: 18.4;ASC TERT1: 7.3"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 1.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (3.61e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.28e-2)"	"unprognostic (4.83e-1)"	"unprognostic (6.60e-3)"	"unprognostic (5.71e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.53e-3)"	"unprognostic (4.07e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.38e-4)"	4.0	2.7	6.1	1.8	9.1	0.9	3.9	19.1	9.6	9.0	2.7	7.7	4.1	1.0	7.6	3.2	3.3	4.7	4.5	4.9	6.9	4.0	1.5	1.2	3.3	1.3	3.2	3.8	6.6	1.7	3.3	3.7	2.7	4.6	5.6	1.6	4.1	2.5	4.0	1.5	3.0	1.5	4.3	6.3	1.4	1.7	1.7	3.7	0.0	1.8	0.9	1.0	2.5	4.2	0.9	0.8	1.6	0.6	1.9	0.7	0.2	0.0	0.4	0.3	0.1	18.4	7.3	0.0	0.8	0.1	0.1	0.3	0.0	0.0	0.8	0.3	0.3	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.2	0.1	0.2	0.1	0.1	1.8	0.2	0.0	0.0	0.6	0.1	0.6	0.7	0.3	0.5	0.7	0.1	0.3	0.9	0.6	0.1	0.0	0.0	0.2	0.3	0.1	0.3	0.3	1.6	0.0	1.0	0.6	0.2	1.0	0.7	0.1	1.0	0.1	0.3	0.2	0.7	1.5	0.6	0.6	0.7	0.3	0.3	0.6	0.6	0.4	0.1	0.9	0.7	0.7	1.6	1.9	0.2	0.8	0.4	0.2	6.1	9.1	19.1	9.6	6.9	4.0	3.2	3.8	4.6	3.7
PDE1A		ENSG00000115252	"Phosphodiesterase 1A"	P54750	2	182140036-182523192	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 66.0;kidney: 37.1"	"Group enriched"	"Detected in some"	5	"ASC diff: 22.3;HHSteC: 13.2;HSkMC: 28.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 13.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	6	"amygdala: 118.0;basal ganglia: 76.2;cerebral cortex: 161.5;hippocampal formation: 155.8;hypothalamus: 47.8"	"Low region specificity"	"Detected in many"			HPA022151	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA022151: AB_1855118"	"unprognostic (3.63e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.84e-1)"	"unprognostic (3.82e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.86e-1)"	"unprognostic (5.55e-3)"	"unprognostic (2.50e-3)"	"unprognostic (5.96e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.40e-3)"	7.6	3.9	13.8	3.6	11.5	0.5	4.1	66.0	25.3	11.5	8.8	6.2	1.7	2.6	7.3	6.7	4.7	7.4	18.2	11.8	12.6	4.1	37.1	3.2	3.1	1.8	7.1	15.7	9.2	2.0	1.3	2.3	1.3	6.9	3.8	5.6	3.0	1.8	4.8	2.4	2.1	4.6	11.8	10.1	2.6	4.6	24.6	9.0	0.0	35.1	2.6	1.1	8.3	9.0	0.0	1.4	0.8	0.2	0.0	0.0	0.0	0.0	0.1	2.2	0.0	22.3	1.8	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.7	0.0	3.1	0.0	13.2	0.0	0.0	28.2	0.0	0.0	0.0	0.0	0.0	4.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	0.0	3.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	13.8	11.5	66.0	25.3	12.6	4.1	7.1	15.7	6.9	9.0
PDGFD	"IEGF, MSTP036, SCDGF-B"	ENSG00000170962	"Platelet derived growth factor D"	Q9GZP0	11	103907186-104164379	"Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Developmental protein, Growth factor, Mitogen"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 48.2"	"Group enriched"	"Detected in some"	6	"ASC diff: 55.5;HHSteC: 16.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"eosinophil: 7.1;gdT-cell: 13.6;memory CD8 T-cell: 5.8;naive CD8 T-cell: 5.1;NK-cell: 12.6"	"Group enriched"	"Detected in many"	27	"granulocytes: 7.1;NK-cells: 12.6;T-cells: 13.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA046183, HPA066271"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"		24000	"Golgi apparatus, Vesicles"		"HPA046183: , HPA066271: "	"unprognostic (2.21e-1)"	"unprognostic (9.35e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.81e-2)"	"unprognostic (8.83e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.01e-3)"	"prognostic unfavourable (9.60e-4)"	"unprognostic (1.19e-1)"	"unprognostic (6.72e-2)"	"unprognostic (3.57e-3)"	26.1	48.2	1.1	10.1	1.5	0.1	21.2	0.6	1.8	13.8	5.6	1.1	15.0	1.5	9.8	10.2	2.7	5.3	20.6	13.9	0.9	1.9	4.3	1.8	2.3	3.5	0.8	1.6	33.4	32.8	5.0	14.4	8.5	6.4	8.5	4.0	16.7	6.0	16.2	9.8	5.1	2.2	4.0	2.1	2.3	8.6	5.4	0.0	1.1	11.5	4.4	4.6	13.5	10.0	0.4	0.0	7.1	0.0	12.6	13.6	2.9	0.0	2.9	1.5	0.0	55.5	1.6	0.0	0.3	0.3	0.2	0.3	0.0	0.5	2.7	0.5	2.7	0.1	0.0	0.0	0.1	0.0	1.2	0.0	0.6	0.1	16.9	0.0	0.0	5.8	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.8	0.0	2.6	0.0	0.0	3.7	0.0	5.3	1.2	0.0	0.7	0.4	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	7.1	13.6	0.0	1.1	0.4	1.5	5.8	0.0	0.0	0.1	5.1	0.2	12.6	0.0	0.0	0.1	2.9	1.1	1.5	0.6	1.8	0.9	1.9	0.8	1.6	6.4	0.0
PDGFRB	"CD140b, JTK12, PDGFR, PDGFR1"	ENSG00000113721	"Platelet derived growth factor receptor beta"	P09619	5	150113837-150155872	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	Chemotaxis	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"ASC diff: 169.0;ASC TERT1: 58.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.9;non-classical monocyte: 4.1"	"Group enriched"	"Detected in many"	8	"monocytes: 4.1;T-cells: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003842, CAB018144, HPA028499"	Enhanced		Supported	"Golgi apparatus,Vesicles"			35000000	Vesicles	"Golgi apparatus"	"CAB003842: AB_562328, CAB018144: AB_2162497, HPA028499: AB_10602018"	"unprognostic (4.75e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.27e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.57e-3)"	"unprognostic (6.72e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (5.87e-8)"	"unprognostic (3.13e-3)"	"unprognostic (1.25e-2)"	"unprognostic (5.47e-2)"	"prognostic unfavourable (8.11e-4)"	61.8	10.4	8.3	11.0	9.1	0.5	66.1	4.6	10.4	73.1	15.7	6.7	6.9	5.1	44.3	17.3	21.7	26.1	51.7	24.2	8.2	3.9	17.0	4.6	28.9	21.5	7.9	8.1	46.5	7.5	10.4	7.7	46.4	7.7	24.2	6.3	22.9	11.2	19.3	29.8	20.3	11.2	29.8	5.0	19.6	9.2	21.5	6.7	1.4	21.4	16.0	7.3	23.6	35.1	0.4	0.1	0.0	4.1	0.0	2.9	0.6	0.0	0.0	1.0	0.0	169.0	58.5	0.3	5.9	24.5	4.1	7.0	0.6	0.0	0.0	0.7	16.9	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.3	0.4	24.0	0.0	0.0	26.3	0.0	5.7	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	1.1	0.0	0.4	0.3	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	6.7	2.2	2.8	0.3	0.0	0.0	0.0	4.1	0.0	0.1	0.0	0.0	0.0	2.9	0.6	0.0	0.4	0.1	0.8	0.1	0.1	0.0	1.3	0.0	0.0	4.1	0.0	0.0	0.6	8.3	9.1	4.6	10.4	8.2	3.9	7.9	8.1	7.7	6.7
PFKFB1	PFRX	ENSG00000158571	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1"	P16118	X	54932961-54998534	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Kinase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 24.2;liver: 24.4;skeletal muscle: 48.3"	"Group enriched"	"Detected in some"	4	"ASC diff: 13.6;Hep G2: 5.4"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 7.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (2.51e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.64e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.33e-1)"	"unprognostic (3.26e-3)"	"unprognostic (2.88e-1)"	"unprognostic (5.36e-3)"	"unprognostic (5.06e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.16e-4)"	"unprognostic (1.96e-3)"	24.2	0.2	0.1	1.6	0.1	0.1	13.1	0.1	0.2	0.1	1.7	0.1	0.1	0.0	0.1	0.2	0.5	0.0	0.1	0.1	0.1	0.1	0.4	24.4	0.1	1.6	0.1	0.1	0.1	0.6	0.2	0.2	0.1	0.1	0.3	0.2	0.1	1.3	0.1	48.3	0.3	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.5	8.3	0.6	0.2	2.0	1.5	0.1	0.0	0.7	1.3	2.1	0.3	0.3	0.2	0.4	0.6	13.6	0.3	1.0	0.0	0.1	0.2	0.0	0.8	0.2	0.6	0.2	0.1	0.5	0.1	0.3	0.4	0.4	1.1	0.4	0.1	5.4	0.0	0.1	0.5	0.2	0.6	0.1	0.4	0.0	0.1	2.1	0.2	0.7	0.6	0.3	0.3	0.3	0.5	0.2	0.1	0.0	0.4	0.4	0.2	0.5	1.5	0.2	0.4	0.0	0.1	0.1	0.5	0.4	0.2	1.1	1.7	0.4	0.2	0.4	0.1	0.0	0.0	0.0	0.2	0.7	2.1	1.5	0.2	0.0	0.0	0.8	0.0	0.8	0.0	1.3	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1
PLIN2	"ADFP, ADRP"	ENSG00000147872	"Perilipin 2"	Q99541	9	19108375-19149290	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 233.1;liver: 139.9"	"Group enriched"	"Detected in many"	5	"ASC diff: 197.8;HHSteC: 171.3"	"Group enriched"	"Detected in all"	5	"liver cancer: 63.0;renal cancer: 136.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 83.5;eosinophil: 76.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 83.5;monocytes: 21.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016607, CAB037331"	Supported		Supported	"Lipid droplets"				"Lipid droplets"		"CAB037331: , HPA016607: "	"unprognostic (2.02e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.02e-2)"	"unprognostic (3.28e-3)"	"unprognostic (4.92e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (3.32e-4)"	"unprognostic (3.14e-3)"	"unprognostic (7.89e-2)"	"prognostic favourable (2.16e-4)"	"unprognostic (1.77e-1)"	233.1	17.4	1.8	6.5	2.8	14.9	98.9	1.1	3.2	11.2	47.4	2.0	5.4	28.4	7.7	7.8	6.2	6.1	10.9	37.0	1.7	1.6	36.0	139.9	18.3	9.6	2.2	1.2	37.5	4.5	2.0	4.7	46.4	3.0	17.1	3.5	5.9	8.5	4.5	75.7	13.5	61.6	6.8	3.1	9.8	5.5	16.5	2.4	4.4	8.8	4.0	4.6	63.2	102.9	3.2	8.6	83.5	21.1	2.0	11.5	11.8	0.0	2.8	3.2	2.3	197.8	27.0	35.9	9.1	7.1	5.5	6.3	4.3	0.6	0.0	0.1	18.6	0.3	3.1	0.0	9.6	11.5	0.0	15.1	0.4	16.1	171.3	1.8	27.8	28.5	3.2	13.6	0.0	6.8	2.7	3.3	21.6	0.7	4.1	6.2	4.3	5.6	10.0	1.5	0.1	0.0	10.6	0.2	5.3	4.2	1.0	9.0	2.2	4.0	10.7	0.0	1.7	8.6	0.0	2.0	2.0	6.1	0.0	3.1	0.8	83.5	14.9	76.1	11.5	19.7	10.0	3.2	10.1	8.2	8.6	2.9	9.9	8.4	0.9	2.0	21.1	1.0	9.6	11.8	1.8	2.8	1.1	3.2	1.7	1.6	2.2	1.2	3.0	2.4
PPP1R1A		ENSG00000135447	"Protein phosphatase 1 regulatory inhibitor subunit 1A"	Q13522	12	54575387-54588659	"Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 67.0;skeletal muscle: 227.2"	"Group enriched"	"Detected in some"	4	"ASC diff: 6.4;NTERA-2: 20.8;RPTEC TERT1: 22.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 17.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"memory B-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"B-cells: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB007811, HPA041542"	Approved									"CAB007811: AB_598171, HPA041542: "	"unprognostic (6.39e-3)"	"unprognostic (2.61e-1)"	"unprognostic (4.61e-3)"	"prognostic unfavourable (2.36e-5)"	"unprognostic (1.55e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.19e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.04e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.76e-3)"	"unprognostic (2.88e-3)"	"unprognostic (7.68e-3)"	"unprognostic (2.17e-1)"	"unprognostic (8.49e-3)"	"unprognostic (7.49e-2)"	67.0	2.1	9.9	1.6	33.2	1.3	51.8	2.2	8.2	1.6	4.0	2.9	0.5	2.2	1.7	1.8	4.3	1.6	1.9	34.6	6.6	3.7	35.4	27.5	1.3	1.4	6.4	4.8	3.3	5.6	3.9	0.1	1.2	4.8	2.9	1.8	0.1	3.1	2.3	227.2	1.3	2.4	2.3	2.7	1.3	4.7	1.7	7.8	0.0	1.4	16.6	1.4	1.4	4.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	3.8	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	20.8	0.0	0.0	0.0	0.1	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	33.2	2.2	8.2	6.6	3.7	6.4	4.8	4.8	7.8
PRELP	"prolargin, SLRR2A"	ENSG00000188783	"Proline and arginine rich end leucine rich repeat protein"	P51888	1	203475828-203491352	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 183.7"	"Group enriched"	"Detected in some"	9	"ASC diff: 18.5;BJ: 7.5;fHDF/TERT166: 11.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"		280000				"unprognostic (1.98e-1)"	"unprognostic (7.74e-2)"	"prognostic unfavourable (9.70e-5)"	"unprognostic (2.83e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (5.62e-6)"	"unprognostic (2.81e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavourable (1.02e-4)"	46.7	16.0	6.3	7.7	5.8	1.1	52.3	3.6	5.0	57.4	35.7	3.7	16.8	5.0	45.3	17.8	46.2	29.5	27.4	58.6	7.0	1.8	8.1	7.3	49.9	5.2	6.4	9.5	62.3	6.6	1.8	7.3	8.3	8.6	48.3	6.6	64.6	10.4	52.5	24.5	16.4	17.0	61.8	7.7	22.6	13.5	23.4	3.3	0.0	25.1	16.1	11.5	98.7	183.7	1.0	1.0	4.0	1.2	1.1	0.8	0.6	0.2	0.2	0.5	0.2	18.5	0.5	0.5	7.5	1.0	0.2	0.2	0.0	0.2	1.1	0.7	11.4	0.7	0.2	0.3	0.3	0.1	0.2	0.4	0.4	0.2	0.0	0.3	0.2	0.0	0.1	0.1	0.2	0.1	0.2	0.5	1.3	0.1	0.2	0.5	0.5	0.1	0.4	0.2	0.5	0.0	0.3	1.1	0.3	0.2	0.2	0.8	0.3	0.2	0.6	0.5	0.3	0.3	0.1	0.3	0.4	1.2	0.1	0.2	0.5	4.0	1.2	1.7	0.7	1.0	0.8	0.6	0.7	0.5	0.4	1.0	0.7	0.6	2.7	1.1	1.1	1.0	0.6	0.6	6.3	5.8	3.6	5.0	7.0	1.8	6.4	9.5	8.6	3.3
PTGDR	"DP, DP1, PTGDR1"	ENSG00000168229	"Prostaglandin D2 receptor"	Q13258	14	52267713-52276724	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	Asthma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 30.1"	"Group enriched"	"Detected in some"	4	"ASC diff: 1.4;HSkMC: 1.5;REH: 2.4;U-138 MG: 1.8"	"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in many"		"pons and medulla: 13.9"	"Group enriched"	"Detected in many"	5	"gdT-cell: 25.4;MAIT T-cell: 12.7;memory CD8 T-cell: 15.2;naive CD8 T-cell: 8.9;NK-cell: 30.1"	"Group enriched"	"Detected in many"	30	"NK-cells: 30.1;T-cells: 25.4"	"Low region specificity"	"Detected in many"							HPA049668	Enhanced									"HPA049668: "	"unprognostic (9.32e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.04e-3)"	"unprognostic (4.80e-2)"	"unprognostic (2.70e-2)"	"unprognostic (3.11e-3)"	"unprognostic (5.00e-2)"	"unprognostic (9.38e-3)"	"unprognostic (4.94e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.60e-8)"	"unprognostic (1.14e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.02e-2)"	"unprognostic (5.89e-2)"	3.9	0.9	0.7	9.6	2.5	1.8	9.3	1.4	1.4	5.5	10.0	0.7	0.9	1.1	4.1	2.2	2.1	2.5	4.9	2.3	0.8	0.8	1.5	1.8	3.4	8.9	1.0	3.5	2.3	0.8	0.8	4.5	0.4	13.9	2.1	12.8	11.2	2.6	3.5	0.9	1.3	2.4	2.0	3.6	10.9	2.0	0.9	0.8	1.8	2.5	0.1	3.1	3.3	3.2	0.0	0.0	0.9	0.1	30.1	25.4	4.1	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	25.4	0.0	12.7	0.0	3.5	15.2	0.0	0.0	0.6	8.9	0.9	30.1	0.1	0.0	0.0	4.1	0.7	2.5	1.4	1.4	0.8	0.8	1.0	3.5	13.9	0.8
PTGIS	"CYP8A1, PGIS"	ENSG00000124212	"Prostaglandin I2 synthase"	Q16647	20	49503874-49568146	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Isomerase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 88.2"	"Group enriched"	"Detected in some"	4	"ASC diff: 17.4;ASC TERT1: 17.5;U-2197: 53.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009517, HPA014193, HPA052244"	Enhanced		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"CAB009517: AB_2173209, HPA014193: AB_1855746, HPA052244: "	"unprognostic (7.68e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.45e-2)"	"unprognostic (5.22e-2)"	"prognostic unfavourable (4.74e-8)"	"unprognostic (2.29e-2)"	"unprognostic (7.61e-2)"	"unprognostic (4.89e-3)"	"prognostic unfavourable (9.99e-5)"	18.2	2.5	0.6	8.0	1.3	0.1	28.3	0.2	1.6	23.3	14.6	0.5	6.5	1.7	36.5	21.7	13.2	32.0	36.3	23.8	0.3	0.5	3.0	3.8	7.5	1.6	0.5	0.9	51.2	1.3	0.2	0.5	1.0	1.0	27.2	3.7	3.2	3.7	4.6	7.0	3.2	4.4	88.2	1.4	0.3	8.7	16.2	0.3	0.0	6.7	5.6	1.7	64.2	36.1	1.0	0.8	2.7	0.6	0.8	0.5	0.1	0.0	0.0	0.7	0.0	17.4	17.5	0.2	0.3	2.1	0.0	0.0	0.0	0.0	0.0	6.9	5.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	1.2	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	53.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.6	0.4	0.4	0.4	0.3	0.4	0.3	0.3	0.1	1.0	0.4	0.5	2.7	0.8	0.3	0.8	0.2	0.1	0.6	1.3	0.2	1.6	0.3	0.5	0.5	0.9	1.0	0.3
RNASE4	RAB1	ENSG00000258818	"Ribonuclease A family member 4"	P34096	14	20684100-20701215	"Plasma proteins, Predicted secreted proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"liver: 366.2"	"Group enriched"	"Detected in many"	4	"ASC diff: 30.8;ASC TERT1: 34.9;Hep G2: 43.4;HSkMC: 20.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 17.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"												"Secreted to blood"		27000000				"unprognostic (1.07e-1)"	"unprognostic (3.46e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.18e-4)"	"unprognostic (1.20e-1)"	"unprognostic (7.05e-2)"	"prognostic favourable (9.62e-5)"	"unprognostic (1.43e-1)"	"unprognostic (2.22e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.16e-2)"	"unprognostic (4.27e-2)"	29.6	1.7	1.5	5.7	1.8	0.2	28.7	1.0	1.2	25.2	16.3	2.5	12.3	4.9	19.2	18.4	14.7	15.7	23.4	10.3	2.3	1.0	18.9	366.2	12.8	5.2	3.0	1.4	30.8	16.3	3.8	3.0	4.4	2.7	30.4	15.0	10.5	35.0	14.2	7.1	10.6	13.6	17.4	3.8	3.2	19.2	13.2	1.9	0.3	8.4	10.5	7.3	25.1	26.3	4.0	9.7	0.5	17.0	0.4	2.5	5.0	0.8	4.1	0.8	0.0	30.8	34.9	0.2	3.3	7.6	0.5	1.4	1.0	1.1	0.0	0.8	7.7	0.8	0.4	0.8	0.6	5.3	0.4	0.0	0.9	43.4	3.4	0.4	0.1	20.8	1.9	0.5	3.5	4.0	0.0	3.7	2.2	0.5	0.2	0.0	0.1	3.3	0.1	0.6	1.1	0.7	0.7	0.0	0.1	1.2	0.6	0.8	0.9	0.1	4.1	0.9	0.5	1.2	0.1	0.7	0.9	0.1	1.4	0.3	0.8	0.1	17.0	0.0	0.6	0.9	0.8	4.0	1.1	0.4	9.7	2.2	0.2	0.4	0.5	0.4	0.1	2.3	2.5	5.0	1.5	1.8	1.0	1.2	2.3	1.0	3.0	1.4	2.7	1.9
SERPING1	"C1-INH, C1IN, C1NH, HAE1, HAE2"	ENSG00000149131	"Serpin family G member 1"	P05155	11	57597387-57614853	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Complement pathway, Fibrinolysis, Hemostasis, Immunity, Innate immunity"	"Protease inhibitor, Serine protease inhibitor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"liver: 693.2"	"Group enriched"	"Detected in some"	6	"ASC diff: 144.9;ASC TERT1: 75.1;HSkMC: 124.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 609.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 8.9;intermediate monocyte: 11.0;neutrophil: 32.1;plasmacytoid DC: 28.5"	"Group enriched"	"Detected in many"	143	"dendritic cells: 28.5;granulocytes: 32.1;monocytes: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026161, HPA048738"	Supported				"Secreted to blood"		38000000000			"CAB026161: , HPA048738: "	"unprognostic (1.35e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavourable (9.96e-4)"	"unprognostic (4.26e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.12e-3)"	"unprognostic (2.13e-1)"	"unprognostic (8.95e-2)"	"prognostic favourable (8.03e-4)"	"unprognostic (5.92e-3)"	"unprognostic (3.76e-2)"	"prognostic unfavourable (1.55e-4)"	"unprognostic (2.60e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.17e-1)"	88.8	16.3	3.6	18.2	5.4	1.6	75.0	3.8	6.3	62.7	37.8	7.3	16.7	6.2	63.4	58.8	58.3	63.4	61.6	55.5	3.4	3.0	53.4	693.2	73.8	22.4	5.7	4.1	116.4	38.1	8.0	18.4	33.1	14.9	70.3	11.9	82.6	20.7	33.2	36.5	23.1	20.3	38.7	17.3	42.7	30.3	39.2	3.6	1.8	41.5	24.4	16.8	68.7	122.2	0.0	28.5	32.1	11.0	0.1	0.0	2.8	0.0	0.0	5.5	0.0	144.9	75.1	0.9	9.2	6.5	1.9	3.5	0.3	0.0	0.0	11.1	4.7	0.0	0.0	0.6	1.2	0.0	0.0	4.5	0.0	0.2	19.2	0.2	0.9	124.5	1.8	0.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	5.6	0.0	0.7	0.4	0.0	0.8	0.0	0.0	1.8	0.0	0.0	0.1	0.1	0.4	0.0	0.3	2.9	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	8.9	0.1	0.0	11.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	32.1	0.1	4.4	28.5	0.0	2.8	3.6	5.4	3.8	6.3	3.4	3.0	5.7	4.1	14.9	3.6
SFRP2	"FRP-2, SARP1, SDF-5"	ENSG00000145423	"Secreted frizzled related protein 2"	Q96HF1	4	153780592-153789120	"Predicted secreted proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"urinary bladder: 102.5"	"Group enriched"	"Detected in some"	12	"AF22: 52.3;ASC diff: 19.9;HSkMC: 32.8;NTERA-2: 72.5"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 370.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA002652			Approved	"Intermediate filaments"	"Secreted in other tissues"			"Intermediate filaments"		"HPA002652: AB_1079937"	"unprognostic (2.63e-1)"	"unprognostic (2.47e-1)"	"unprognostic (7.21e-3)"	"unprognostic (1.80e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.80e-3)"	"unprognostic (5.71e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.47e-3)"	"unprognostic (1.44e-2)"	"unprognostic (5.29e-2)"	"prognostic unfavourable (8.56e-6)"	"unprognostic (9.29e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavourable (4.39e-4)"	42.9	4.0	3.4	17.6	1.7	0.2	70.0	1.3	8.0	10.9	20.6	11.3	18.2	4.4	6.4	64.4	51.5	18.5	74.9	42.2	8.5	1.2	1.9	0.2	21.3	2.6	2.8	5.6	7.9	22.5	1.6	23.2	0.3	4.6	33.4	10.8	8.4	23.9	19.5	2.5	26.1	13.7	72.3	5.4	0.3	11.4	13.2	5.0	0.3	29.1	29.4	6.8	102.5	37.4	0.0	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.0	52.3	0.0	19.9	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.4	1.7	1.3	5.7	8.5	1.2	2.8	5.6	4.6	5.0
SVEP1	"bA427L11.3, C9orf13, FLJ13529, POLYDOM"	ENSG00000165124	"Sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1"	Q4LDE5	9	110365251-110579880	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"placenta: 141.1"	"Group enriched"	"Detected in some"	5	"ASC diff: 50.4;ASC TERT1: 29.3;BJ hTERT+: 20.6;HHSteC: 18.5;HSkMC: 22.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 6.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in some"	7	"cerebellum: 31.1"	"HPA020610, HPA021520"	Enhanced				"Intracellular and membrane"		160000000			"HPA020610: AB_2197021, HPA021520: AB_1855533"	"unprognostic (4.47e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.62e-2)"	"unprognostic (9.13e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.08e-2)"	"unprognostic (3.31e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.11e-2)"	"prognostic unfavourable (8.33e-4)"	"unprognostic (9.84e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.55e-3)"	18.8	2.5	1.0	3.9	1.8	0.0	11.9	6.7	0.9	7.1	8.6	0.5	3.6	0.6	6.1	7.8	4.7	4.4	5.4	4.4	1.1	0.7	2.1	1.5	8.6	5.8	1.1	0.5	4.2	2.7	2.2	0.7	141.1	0.7	4.3	3.1	1.5	2.2	1.3	7.4	3.5	3.3	5.7	0.6	3.4	3.6	4.0	0.9	0.0	3.5	2.3	1.3	9.6	7.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	50.4	29.3	0.0	5.3	20.6	0.4	0.6	0.5	0.0	0.0	0.0	1.2	0.0	0.0	4.0	0.3	0.0	0.1	0.0	0.4	0.0	18.5	0.0	1.0	22.9	0.0	4.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	2.4	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.4	0.8	0.0	2.5	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.8	6.7	0.9	1.1	0.7	1.1	0.5	0.7	0.9
TMEM132C	"DKFZp761O2018, PPP1R152"	ENSG00000181234	"Transmembrane protein 132C"	Q8N3T6	12	128267403-128707915	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 37.5"	"Group enriched"	"Detected in some"	6	"AF22: 5.9;ASC diff: 8.5;Daudi: 9.5"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 4.6;testis cancer: 4.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"gdT-cell: 5.4"	"Lineage enriched"	"Detected in single"	55	"T-cells: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015633, HPA015984"			Supported	Centrosome,Cytosol			110000000	"Centrosome, Cytosol"		"HPA015633: AB_1858089, HPA015984: AB_1858088"	"unprognostic (2.29e-2)"	"unprognostic (5.55e-3)"	"unprognostic (7.34e-2)"	"unprognostic (8.60e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.99e-3)"		"unprognostic (5.48e-2)"		"unprognostic (1.30e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.85e-2)"	"unprognostic (6.29e-2)"	"unprognostic (7.97e-3)"	"unprognostic (2.54e-1)"	"unprognostic (5.71e-2)"	"unprognostic (6.33e-3)"	37.5	4.2	9.6	1.1	7.0	0.8	23.3	5.0	6.6	22.0	2.5	4.2	8.9	1.2	5.9	5.7	4.7	13.4	5.1	3.5	5.0	3.8	1.3	0.8	1.6	2.0	4.9	3.1	7.9	4.1	0.9	0.6	5.1	4.6	3.7	1.3	5.3	2.9	9.1	1.9	2.2	1.4	2.1	3.9	1.1	1.5	2.1	5.4	0.0	1.1	0.9	1.3	3.8	10.5	0.0	0.0	0.0	0.0	0.0	5.4	0.1	0.0	0.0	5.9	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	9.6	7.0	5.0	6.6	5.0	3.8	4.9	3.1	4.6	5.4
TMEM196	MGC42090	ENSG00000173452	"Transmembrane protein 196"	Q5HYL7	7	19719310-19773598	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 15.0;pituitary gland: 12.6"	"Group enriched"	"Detected in some"	9	"ASC diff: 8.6;ASC TERT1: 8.5"	"Cancer enhanced"	"Detected in single"		"glioma: 0.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA043163	Uncertain		Uncertain	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"			"Nucleoplasm, Golgi apparatus"		"HPA043163: AB_10794772"					"unprognostic (6.08e-3)"					"unprognostic (1.88e-2)"	"unprognostic (2.14e-2)"		"unprognostic (9.30e-2)"	"unprognostic (5.63e-2)"				0.7	3.7	8.0	0.6	8.6	0.4	0.4	0.3	15.0	1.2	0.6	0.3	0.0	0.4	3.8	1.5	0.5	1.2	0.4	0.4	3.6	10.1	0.6	0.4	0.4	0.4	2.9	7.4	0.4	3.0	0.7	12.6	0.4	5.0	0.5	0.5	0.5	0.4	0.4	0.4	0.4	0.4	1.0	1.4	0.4	2.6	0.5	2.8	0.0	0.4	0.0	0.4	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	8.6	8.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	8.6	0.3	7.3	3.6	10.1	2.9	7.4	5.0	2.8
TRIM63	"IRF, MURF-1, RNF28, SMRZ"	ENSG00000158022	"Tripartite motif containing 63"	Q969Q1	1	26051304-26068436	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Muscle protein, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skeletal muscle: 271.4"	"Group enriched"	"Detected in some"	38	"ASC diff: 10.5;SK-MEL-30: 33.5"	"Cancer enriched"	"Detected in some"	10	"melanoma: 31.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (1.10e-1)"	"unprognostic (4.80e-4)"	"unprognostic (1.45e-2)"	"unprognostic (7.52e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.16e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.58e-2)"	3.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	1.2	1.7	0.0	0.6	38.2	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.1	0.5	0.0	3.6	1.0	0.0	271.4	0.6	0.1	0.9	0.1	0.0	0.1	0.1	0.0	0.0	1.7	12.7	0.8	1.2	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
VIT		ENSG00000205221	Vitrin	Q6UXI7	2	36696690-36814792	"Predicted intracellular proteins, Predicted secreted proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"ASC diff: 13.8;ASC TERT1: 27.1;BJ: 13.0;fHDF/TERT166: 43.9;THP-1: 13.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	8	"gdT-cell: 5.3;memory CD8 T-cell: 2.3;naive CD8 T-cell: 3.4"	"Lineage enriched"	"Detected in single"	11	"T-cells: 5.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to extracellular matrix"		120000				"unprognostic (5.34e-4)"	"unprognostic (4.49e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.78e-3)"	"unprognostic (8.32e-2)"		"unprognostic (1.81e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.66e-6)"	"unprognostic (2.09e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.62e-3)"	"unprognostic (1.41e-2)"	25.5	1.2	0.2	0.6	0.4	0.9	10.3	2.5	1.0	7.4	2.1	0.3	6.3	0.6	1.9	11.4	17.1	5.0	2.7	14.2	0.2	0.1	0.5	0.2	1.2	2.3	3.4	0.7	30.0	2.2	1.0	2.0	6.8	1.0	15.3	1.7	18.1	7.8	2.9	11.6	8.3	1.5	20.5	5.1	0.3	3.4	10.5	0.0	0.0	7.9	22.0	3.9	21.4	10.9	0.0	0.0	0.0	0.1	0.4	5.3	1.1	0.0	0.0	0.0	0.0	13.8	27.1	0.0	13.0	3.0	4.2	1.7	0.0	0.0	0.0	0.0	43.9	0.0	2.4	0.0	2.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	1.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.2	2.3	0.0	0.0	0.0	3.4	0.0	0.4	0.1	0.0	0.0	1.1	0.2	0.4	2.5	0.6	0.2	0.1	3.4	0.7	1.0	0.0
XG	PBDX	ENSG00000124343	"Xg blood group"	P55808	X	2752048-2816500	"Blood group antigen proteins, Predicted membrane proteins"		"Blood group antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 22.8;placenta: 18.4;skin 1: 25.8"	"Group enriched"	"Detected in some"	6	"ASC diff: 33.7;ASC TERT1: 25.0;fHDF/TERT166: 15.7;hTCEpi: 23.4;T-47d: 12.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	16	"memory B-cell: 2.1;naive B-cell: 1.0"	"Lineage enriched"	"Detected in single"	21	"B-cells: 2.1"					"Low region specificity"	"Detected in all"														"prognostic unfavourable (4.25e-4)"	"unprognostic (1.69e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.55e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.86e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.16e-2)"	"unprognostic (8.62e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.10e-6)"	"unprognostic (3.96e-3)"	"unprognostic (7.98e-2)"	"unprognostic (5.83e-3)"	"unprognostic (6.77e-3)"	8.9	0.0	0.3	0.3	0.6	0.8	9.1	0.5	0.6	22.8	0.3	0.3	0.3	0.0	2.6	0.3	7.1	0.6	3.0	1.2	1.4	0.0	1.3	0.3	0.3	0.3	0.6	0.3	1.1	0.3	0.0	0.3	18.4	1.9	0.5	0.0	0.3	4.1	0.4	1.4	25.8	0.3	0.3	4.2	0.3	0.1	0.3	0.3	0.3	0.9	0.3	2.4	1.2	7.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.7	25.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.7	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	23.4	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.1	1.7	12.6	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.5	0.6	1.4	0.0	0.6	0.3	1.9	0.3